10-Q 1 form10-q.htm
false Q2 --12-31 0001648087 P5Y P5Y http://fasb.org/us-gaap/2024#OperatingLeaseRightOfUseAsset http://fasb.org/us-gaap/2024#OperatingLeaseRightOfUseAsset 0001648087 2024-01-01 2024-06-30 0001648087 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0001648087 AREB:CommonStockPurchaseWarrantsMember 2024-01-01 2024-06-30 0001648087 2024-08-14 0001648087 2024-06-30 0001648087 2023-12-31 0001648087 srt:OfficerMember 2024-06-30 0001648087 srt:OfficerMember 2023-12-31 0001648087 srt:DirectorMember 2024-06-30 0001648087 srt:DirectorMember 2023-12-31 0001648087 us-gaap:SeriesAPreferredStockMember 2024-06-30 0001648087 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001648087 us-gaap:SeriesBPreferredStockMember 2024-06-30 0001648087 us-gaap:SeriesBPreferredStockMember 2023-12-31 0001648087 us-gaap:SeriesDPreferredStockMember 2024-06-30 0001648087 us-gaap:SeriesDPreferredStockMember 2023-12-31 0001648087 2024-04-01 2024-06-30 0001648087 2023-04-01 2023-06-30 0001648087 2023-01-01 2023-06-30 0001648087 us-gaap:CommonStockMember 2023-03-31 0001648087 us-gaap:PreferredStockMember 2023-03-31 0001648087 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001648087 us-gaap:RetainedEarningsMember 2023-03-31 0001648087 2023-03-31 0001648087 us-gaap:CommonStockMember 2024-03-31 0001648087 us-gaap:PreferredStockMember 2024-03-31 0001648087 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001648087 us-gaap:RetainedEarningsMember 2024-03-31 0001648087 2024-03-31 0001648087 us-gaap:CommonStockMember 2022-12-31 0001648087 us-gaap:PreferredStockMember 2022-12-31 0001648087 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001648087 us-gaap:RetainedEarningsMember 2022-12-31 0001648087 2022-12-31 0001648087 us-gaap:CommonStockMember 2023-12-31 0001648087 us-gaap:PreferredStockMember 2023-12-31 0001648087 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001648087 us-gaap:RetainedEarningsMember 2023-12-31 0001648087 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001648087 us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001648087 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001648087 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001648087 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001648087 us-gaap:PreferredStockMember 2024-04-01 2024-06-30 0001648087 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001648087 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001648087 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001648087 us-gaap:PreferredStockMember 2023-01-01 2023-06-30 0001648087 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001648087 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001648087 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0001648087 us-gaap:PreferredStockMember 2024-01-01 2024-06-30 0001648087 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-06-30 0001648087 us-gaap:RetainedEarningsMember 2024-01-01 2024-06-30 0001648087 us-gaap:CommonStockMember 2023-06-30 0001648087 us-gaap:PreferredStockMember 2023-06-30 0001648087 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001648087 us-gaap:RetainedEarningsMember 2023-06-30 0001648087 2023-06-30 0001648087 us-gaap:CommonStockMember 2024-06-30 0001648087 us-gaap:PreferredStockMember 2024-06-30 0001648087 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001648087 us-gaap:RetainedEarningsMember 2024-06-30 0001648087 AREB:PreFundedCommonStockWarrantsMember 2023-04-01 2023-06-30 0001648087 AREB:PreFundedCommonStockWarrantsMember 2023-06-30 0001648087 AREB:PreFundedCommonStockWarrantsMember 2023-01-01 2023-06-30 0001648087 srt:MinimumMember 2024-06-30 0001648087 srt:MaximumMember 2024-06-30 0001648087 2023-01-01 2023-12-31 0001648087 us-gaap:SupplierConcentrationRiskMember AREB:InventoryMember AREB:TwoThirdPartyVendorMember 2022-01-01 2022-12-31 0001648087 us-gaap:SupplierConcentrationRiskMember AREB:InventoryMember AREB:TwoThirdPartyVendorMember 2024-01-01 2024-06-30 0001648087 AREB:TwoThirdPartyVendorMember 2024-06-30 0001648087 AREB:TwoThirdPartyVendorMember 2023-12-31 0001648087 AREB:SafesMember 2024-04-01 2024-06-30 0001648087 AREB:SafesMember 2023-04-01 2023-06-30 0001648087 AREB:SafesMember 2024-01-01 2024-06-30 0001648087 AREB:SafesMember 2023-01-01 2023-06-30 0001648087 AREB:SoftGoodsMember 2024-04-01 2024-06-30 0001648087 AREB:SoftGoodsMember 2023-04-01 2023-06-30 0001648087 AREB:SoftGoodsMember 2024-01-01 2024-06-30 0001648087 AREB:SoftGoodsMember 2023-01-01 2023-06-30 0001648087 AREB:BeveragesMember 2024-04-01 2024-06-30 0001648087 AREB:BeveragesMember 2023-04-01 2023-06-30 0001648087 AREB:BeveragesMember 2024-01-01 2024-06-30 0001648087 AREB:BeveragesMember 2023-01-01 2023-06-30 0001648087 us-gaap:PropertyPlantAndEquipmentMember 2024-06-30 0001648087 us-gaap:PropertyPlantAndEquipmentMember 2023-12-31 0001648087 us-gaap:VehiclesMember 2024-06-30 0001648087 us-gaap:VehiclesMember 2023-12-31 0001648087 AREB:CharlesARossJrMember 2024-04-01 2024-06-30 0001648087 AREB:CharlesARossJrMember 2023-04-01 2023-06-30 0001648087 AREB:CharlesARossJrMember 2024-01-01 2024-06-30 0001648087 AREB:CharlesARossJrMember 2023-01-01 2023-06-30 0001648087 AREB:MrGrauMember 2024-04-01 2024-06-30 0001648087 AREB:MrGrauMember 2023-04-01 2023-06-30 0001648087 AREB:MrGrauMember 2024-01-01 2024-06-30 0001648087 AREB:MrGrauMember 2023-01-01 2023-06-30 0001648087 AREB:MrGrauMember 2024-06-30 0001648087 AREB:MrLambrechtsEmploymentAgreementMember 2023-11-19 2023-11-20 0001648087 AREB:MrLambrechtsEmploymentAgreementMember AREB:IndependentDirectorMember 2024-01-01 2024-06-30 0001648087 AREB:MrLambrechtsEmploymentAgreementMember AREB:IndependentConsultantMember 2023-01-01 2023-06-30 0001648087 AREB:MrLambrechtMember AREB:MrLambrechtsEmploymentAgreementMember 2024-01-01 2024-06-30 0001648087 AREB:MrLambrechtMember AREB:MrLambrechtsEmploymentAgreementMember 2023-11-20 2023-11-20 0001648087 AREB:MrLambrechtMember AREB:MrLambrechtsEmploymentAgreementMember 2023-10-01 2023-12-31 0001648087 AREB:MrLambrechtMember AREB:MrLambrechtsEmploymentAgreementMember us-gaap:PreferredStockMember 2024-01-01 2024-01-01 0001648087 AREB:MrLambrechtMember AREB:MrLambrechtsEmploymentAgreementMember us-gaap:CommonStockMember 2024-01-01 2024-01-01 0001648087 AREB:MrRossAmendedEmploymentAgreementMember 2023-10-31 2023-10-31 0001648087 AREB:MrRossAmendedEmploymentAgreementMember 2023-10-01 2023-12-31 0001648087 AREB:MrRossAmendedEmploymentAgreementMember 2024-01-01 2024-06-30 0001648087 AREB:MrRossAmendedEmploymentAgreementMember us-gaap:PreferredStockMember 2024-01-01 2024-01-01 0001648087 AREB:MrRossAmendedEmploymentAgreementMember us-gaap:CommonStockMember 2024-01-01 2024-01-01 0001648087 AREB:MrGrausAmendedEmploymentAgreementMember 2023-10-31 2023-10-31 0001648087 AREB:MrGrausAmendedEmploymentAgreementMember 2023-10-01 2023-12-31 0001648087 AREB:MrGrausAmendedEmploymentAgreementMember 2024-01-01 2024-06-30 0001648087 srt:DirectorMember AREB:PromissoryNoteMember 2024-06-28 0001648087 srt:DirectorMember AREB:PromissoryNoteMember 2024-06-28 2024-06-28 0001648087 srt:DirectorMember AREB:PromissoryNoteMember us-gaap:SubsequentEventMember 2024-08-31 2024-08-31 0001648087 us-gaap:RelatedPartyMember AREB:WorkingCapitalLoanMember 2024-06-30 0001648087 us-gaap:RelatedPartyMember AREB:WorkingCapitalLoanMember 2023-12-31 0001648087 us-gaap:RelatedPartyMember 2024-06-30 0001648087 us-gaap:RelatedPartyMember 2023-12-31 0001648087 AREB:WorkingCapitalLoanMember AREB:PriorToJulyThirtyOneTwoThousandTwentyFourMember 2024-06-28 0001648087 AREB:WorkingCapitalLoanMember AREB:PriorToAugustThirtyOneTwoThousandTwentyFourMember 2024-06-28 0001648087 AREB:WorkingCapitalLoanMember AREB:PriorToSeptemberThirtyTwoThousandTwentyFourMember 2024-06-28 0001648087 AREB:WorkingCapitalLoanMember 2023-12-31 0001648087 AREB:WorkingCapitalLoanMember AREB:FirstLoanMember 2023-12-31 0001648087 AREB:WorkingCapitalLoanMember AREB:SecondLoanMember 2024-01-01 2024-06-30 0001648087 AREB:WorkingCapitalLoanMember AREB:SecondLoanMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanMember 2023-01-01 2023-12-31 0001648087 AREB:WorkingCapitalLoanOneMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanOneMember 2023-12-31 0001648087 AREB:WorkingCapitalLoanMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanMember 2024-01-01 2024-06-30 0001648087 AREB:WorkingCapitalLoanTwoMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanTwoMember 2023-12-31 0001648087 AREB:WorkingCapitalLoanTwoMember 2024-01-01 2024-06-30 0001648087 AREB:WorkingCapitalLoanTwoMember 2023-01-01 2023-12-31 0001648087 AREB:WorkingCapitalLoanThreeMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanThreeMember 2023-12-31 0001648087 AREB:WorkingCapitalLoanThreeMember 2024-01-01 2024-06-30 0001648087 AREB:WorkingCapitalLoanThreeMember 2023-01-01 2023-12-31 0001648087 AREB:WorkingCapitalLoanFourMember 2023-01-01 2023-12-31 0001648087 AREB:WorkingCapitalLoanFourMember AREB:PriorToAprilOneTwelveThousandTwentyFourMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanFourMember AREB:PriorToMayFiveTwelveThousandTwentyFourMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanFourMember AREB:ThereafterMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanFourMember 2024-01-01 2024-06-30 0001648087 AREB:WorkingCapitalLoanFiveMember 2023-01-01 2023-12-31 0001648087 AREB:WorkingCapitalLoanFiveMember AREB:PriorToMayThirtyFirstTwelveThousandTwentyFourMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanFiveMember AREB:PriorToJuneOneTwelveThousandTwentyFourMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanFiveMember 2024-01-01 2024-06-30 0001648087 AREB:WorkingCapitalLoanSixMember 2023-01-01 2023-12-31 0001648087 AREB:WorkingCapitalLoanSixMember AREB:PriorToMayThirtyFirstTwelveThousandTwentyFourMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanSixMember AREB:PriorToMayFiveTwelveThousandTwentyFourMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanSixMember AREB:PriorToJuneOneTwelveThousandTwentyFourMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanSixMember 2024-01-01 2024-06-30 0001648087 AREB:WorkingCapitalLoanSevenMember 2023-01-01 2023-12-31 0001648087 AREB:WorkingCapitalLoanSevenMember AREB:PriorToMayThirtyFirstTwelveThousandTwentyFourMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanSevenMember AREB:PriorToMayFiveTwelveThousandTwentyFourMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanSevenMember AREB:PriorToJuneOneTwelveThousandTwentyFourMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanSevenMember 2024-01-01 2024-06-30 0001648087 AREB:WorkingCapitalLoanEightMember 2023-01-01 2023-12-31 0001648087 AREB:WorkingCapitalLoanEightMember AREB:PriorToMayThirtyFirstTwelveThousandTwentyFourMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanEightMember AREB:PriorToMayFiveTwelveThousandTwentyFourMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanEightMember AREB:PriorToJuneOneTwelveThousandTwentyFourMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanEightMember 2024-01-01 2024-06-30 0001648087 AREB:WorkingCapitalLoanNineMember 2023-01-01 2023-12-31 0001648087 AREB:WorkingCapitalLoanNineMember AREB:PriorToMayThirtyFirstTwelveThousandTwentyFourMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanNineMember AREB:PriorToMayFiveTwelveThousandTwentyFourMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanNineMember AREB:PriorToJuneOneTwelveThousandTwentyFourMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanNineMember 2024-01-01 2024-06-30 0001648087 AREB:WorkingCapitalLoanTenMember 2023-01-01 2023-12-31 0001648087 AREB:WorkingCapitalLoanTenMember AREB:PriorToMayThirtyFirstTwelveThousandTwentyFourMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanTenMember AREB:PriorToMayFiveTwelveThousandTwentyFourMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanTenMember AREB:PriorToJuneOneTwelveThousandTwentyFourMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanTenMember 2024-01-01 2024-06-30 0001648087 AREB:WorkingCapitalLoanElevenMember 2024-01-01 2024-06-30 0001648087 AREB:WorkingCapitalLoanElevenMember 2023-01-01 2023-12-31 0001648087 AREB:WorkingCapitalLoanElevenMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanElevenMember 2023-12-31 0001648087 AREB:WorkingCapitalLoanTwelveMember 2024-01-01 2024-06-30 0001648087 AREB:WorkingCapitalLoanTwelveMember 2023-01-01 2023-12-31 0001648087 AREB:WorkingCapitalLoanThirteenMember 2024-01-01 2024-06-30 0001648087 AREB:WorkingCapitalLoanThirteenMember 2023-01-01 2023-12-31 0001648087 AREB:MasterCreditAgreementMember 2023-02-28 0001648087 AREB:MasterCreditAgreementMember 2024-01-01 2024-06-30 0001648087 AREB:MasterCreditAgreementMember 2023-01-01 2023-12-31 0001648087 AREB:MasterCreditAgreementMember 2023-02-01 2023-02-28 0001648087 AREB:BankOfAmericaMember 2024-01-01 2024-06-30 0001648087 us-gaap:LineOfCreditMember 2024-06-30 0001648087 us-gaap:LineOfCreditMember 2023-12-31 0001648087 AREB:WorkingCapitalLoanFourMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanFourMember 2023-12-31 0001648087 AREB:WorkingCapitalLoanFiveMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanFiveMember 2023-12-31 0001648087 AREB:WorkingCapitalLoanSixMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanSixMember 2023-12-31 0001648087 AREB:WorkingCapitalLoanSevenMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanSevenMember 2023-12-31 0001648087 AREB:WorkingCapitalLoanEightMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanEightMember 2023-12-31 0001648087 AREB:WorkingCapitalLoanNineMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanNineMember 2023-12-31 0001648087 AREB:WorkingCapitalLoanTenMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanTenMember 2023-12-31 0001648087 AREB:WorkingCapitalLoanTwelveMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanTwelveMember 2023-12-31 0001648087 AREB:WorkingCapitalLoanThirteenMember 2024-06-30 0001648087 AREB:WorkingCapitalLoanThirteenMember 2023-12-31 0001648087 us-gaap:SeriesCPreferredStockMember 2024-06-30 0001648087 2023-06-27 2023-06-27 0001648087 2024-04-23 0001648087 AREB:ArmisticeCapitalMasterFundLtdMember 2023-06-27 2023-06-27 0001648087 us-gaap:CommonStockMember AREB:ArmisticeCapitalMasterFundLtdMember 2023-06-27 2023-06-27 0001648087 AREB:ArmisticeCapitalMasterFundLtdMember 2023-06-27 0001648087 AREB:PrefundedWarrantsMember AREB:ArmisticeCapitalMasterFundLtdMember 2023-06-27 0001648087 AREB:PrefundedWarrantsMember AREB:ArmisticeCapitalMasterFundLtdMember 2023-06-27 2023-06-27 0001648087 AREB:ReverseStockSplitMember 2023-07-01 2023-07-31 0001648087 us-gaap:CommonStockMember 2023-07-01 2023-07-31 0001648087 AREB:ArmisticeCapitalMasterFundLtdMember 2024-01-01 2024-06-30 0001648087 AREB:PrefundedWarrantsMember 2023-08-01 2023-08-30 0001648087 AREB:ArmisticeCapitalMasterFundLtdMember 2022-07-08 2022-07-08 0001648087 AREB:ArmisticeCapitalMasterFundLtdMember 2023-06-28 2023-06-28 0001648087 AREB:ArmisticeCapitalMasterFundLtdMember 2024-06-30 0001648087 AREB:PreFundedCommonStockWarrantsMember 2024-06-30 0001648087 AREB:ArmisticeCapitalMasterFundLtdMember 2024-06-30 0001648087 AREB:ArmisticeCapitalMasterFundLtdMember 2024-06-30 0001648087 us-gaap:CommonStockMember AREB:SeptemberTwentyOneMember 2024-01-01 2024-06-30 0001648087 us-gaap:CommonStockMember AREB:SeptemberTwelveMember 2024-01-01 2024-06-30 0001648087 AREB:ArmisticeCapitalMasterFundLtdMember AREB:SeptemberTwelveMember 2024-06-30 0001648087 AREB:PrefundedWarrantsMember 2023-09-08 0001648087 AREB:PrefundedWarrantsMember 2023-09-08 2023-09-08 0001648087 AREB:PrefundedWarrantsMember 2023-09-19 2023-09-19 0001648087 AREB:PrefundedWarrantsMember 2023-09-19 0001648087 AREB:PrefundedWarrantsMember srt:ChiefExecutiveOfficerMember 2023-09-19 2023-09-19 0001648087 AREB:PrefundedWarrantsMember srt:ChiefOperatingOfficerMember 2023-09-19 2023-09-19 0001648087 2023-09-19 2023-09-19 0001648087 AREB:PrefundedWarrantsMember 2023-09-20 2023-09-20 0001648087 AREB:PrefundedWarrantsMember 2023-09-20 0001648087 2023-09-08 2023-09-08 0001648087 AREB:EmploymentAgreementMember AREB:CEOPresidentAndCOOMember 2023-11-20 0001648087 AREB:EmploymentAgreementMember srt:ChiefOperatingOfficerMember 2023-11-20 2023-11-20 0001648087 AREB:EmploymentAgreementMember srt:ChiefOperatingOfficerMember 2023-11-20 0001648087 AREB:EmploymentAgreementMember srt:ChiefExecutiveOfficerMember 2023-11-20 2023-11-20 0001648087 AREB:EmploymentAgreementMember srt:ChiefExecutiveOfficerMember us-gaap:SeriesAPreferredStockMember 2023-11-20 0001648087 AREB:EmploymentAgreementMember srt:PresidentMember 2023-11-20 2023-11-20 0001648087 AREB:EmploymentAgreementMember srt:PresidentMember us-gaap:SeriesAPreferredStockMember 2023-11-20 0001648087 AREB:SeriesAConvertiblePreferredStockMember 2023-10-30 2023-10-30 0001648087 AREB:SeriesAConvertiblePreferredStockMember 2023-10-31 2023-10-31 0001648087 us-gaap:SeriesAPreferredStockMember AREB:EmploymentMember srt:ChiefOperatingOfficerMember 2023-11-20 2023-11-20 0001648087 us-gaap:SeriesAPreferredStockMember 2023-10-31 2023-10-31 0001648087 us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-12-31 0001648087 us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-01-01 0001648087 us-gaap:IPOMember us-gaap:SeriesCPreferredStockMember srt:MaximumMember 2023-11-03 2023-11-03 0001648087 us-gaap:IPOMember us-gaap:SeriesCPreferredStockMember 2023-11-03 0001648087 us-gaap:IPOMember us-gaap:SeriesCPreferredStockMember 2023-11-03 2023-11-03 0001648087 us-gaap:InvestorMember us-gaap:SeriesCPreferredStockMember 2023-11-03 0001648087 us-gaap:IPOMember us-gaap:SeriesCPreferredStockMember srt:MinimumMember 2023-11-03 0001648087 us-gaap:SeriesCPreferredStockMember 2023-12-31 0001648087 us-gaap:SeriesDPreferredStockMember 2024-05-10 0001648087 AREB:SeriesDConvertiblePreferredStockMember 2024-05-10 0001648087 us-gaap:SeriesCPreferredStockMember 2024-05-10 2024-05-10 0001648087 AREB:SeriesDConvertiblePreferredStockMember 2024-05-13 0001648087 AREB:SeriesDConvertiblePreferredStockMember 2024-05-13 2024-05-13 0001648087 us-gaap:SeriesDPreferredStockMember 2024-05-13 0001648087 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2024-06-30 0001648087 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001648087 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-06-30 0001648087 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001648087 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2024-06-30 0001648087 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001648087 AREB:WarrantsMember 2024-06-30 0001648087 AREB:PrefundedWarrantsMember 2024-06-30 0001648087 AREB:PrefundedWarrantsMember 2022-07-12 2023-12-31 0001648087 us-gaap:CommonStockMember 2022-07-12 2023-12-31 0001648087 2022-11-30 0001648087 AREB:CalvaryFundMember 2022-11-30 2022-11-30 0001648087 AREB:CalvaryFundMember 2022-11-30 0001648087 AREB:PrefundedWarrantsToCalvaryMember 2024-06-30 0001648087 AREB:PrefundedWarrantsToCalvaryMember 2024-01-01 2024-06-30 0001648087 2023-06-27 0001648087 us-gaap:CommonStockMember 2023-06-27 0001648087 us-gaap:WarrantMember 2023-06-27 0001648087 us-gaap:WarrantMember AREB:OfferLetterAgreementMember 2022-07-08 0001648087 us-gaap:WarrantMember AREB:OfferLetterAgreementMember 2023-06-28 0001648087 AREB:ArmisticeCapitalMasterFundLtdMember 2022-07-12 2022-07-12 0001648087 us-gaap:CommonStockMember AREB:ArmisticeCapitalFundLtdMember 2023-06-27 0001648087 AREB:ArmisticeCapitalMasterFundLtdMember 2023-06-27 2023-06-27 0001648087 AREB:PrefundedWarrantsMember 2023-08-21 2023-08-21 0001648087 AREB:PreFundedCommonStockWarrantsMember 2024-01-01 2024-06-30 0001648087 us-gaap:WarrantMember 2023-09-08 2023-09-08 0001648087 us-gaap:WarrantMember 2024-06-30 0001648087 us-gaap:WarrantMember 2023-12-31 0001648087 us-gaap:MeasurementInputSharePriceMember 2024-06-30 0001648087 us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001648087 us-gaap:MeasurementInputExercisePriceMember 2024-06-30 0001648087 us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001648087 us-gaap:MeasurementInputExpectedTermMember 2024-06-30 0001648087 us-gaap:MeasurementInputExpectedTermMember 2023-12-31 0001648087 us-gaap:MeasurementInputPriceVolatilityMember 2024-06-30 0001648087 us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001648087 us-gaap:MeasurementInputExpectedDividendRateMember 2024-06-30 0001648087 us-gaap:MeasurementInputExpectedDividendRateMember 2023-12-31 0001648087 us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-06-30 0001648087 us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001648087 2022-01-01 2022-12-31 0001648087 us-gaap:USTreasuryAndGovernmentMember 2023-01-01 2023-12-31 0001648087 us-gaap:USTreasuryAndGovernmentMember AREB:EmployeeMember 2023-01-01 2023-12-31 0001648087 2024-04-30 0001648087 us-gaap:SubsequentEventMember AREB:FactoringAgreementMember 2024-07-02 2024-07-02 0001648087 us-gaap:SubsequentEventMember AREB:FactoringAgreementMember srt:MinimumMember 2024-07-02 2024-07-02 0001648087 us-gaap:SubsequentEventMember 2024-07-08 0001648087 us-gaap:SubsequentEventMember 2024-07-08 2024-07-08 0001648087 AREB:ConversionAgreementMember us-gaap:SeriesDPreferredStockMember us-gaap:SubsequentEventMember 2024-07-10 0001648087 AREB:ConversionAgreementMember us-gaap:SubsequentEventMember 2024-07-10 2024-07-10 0001648087 AREB:ConversionAgreementMember us-gaap:SubsequentEventMember 2024-07-10 0001648087 AREB:ConversionAgreementMember us-gaap:SubsequentEventMember 2024-07-09 0001648087 AREB:ConversionAgreementMember us-gaap:SeriesDPreferredStockMember us-gaap:SubsequentEventMember srt:MaximumMember 2024-07-10 0001648087 AREB:ConversionAgreementMember us-gaap:SeriesDPreferredStockMember us-gaap:SubsequentEventMember srt:MinimumMember 2024-07-10 0001648087 us-gaap:SubsequentEventMember 2024-07-22 2024-07-22 0001648087 us-gaap:SubsequentEventMember 2024-07-22 0001648087 us-gaap:SubsequentEventMember AREB:BankOfAmericaMember 2024-07-25 0001648087 us-gaap:SubsequentEventMember AREB:BankOfAmericaMember 2024-07-25 2024-07-25 0001648087 us-gaap:SubsequentEventMember AREB:AccreditedInvestorOneMember us-gaap:SeriesDPreferredStockMember 2024-08-05 2024-08-05 0001648087 us-gaap:SubsequentEventMember AREB:AccreditedInvestorTwoMember us-gaap:SeriesDPreferredStockMember 2024-08-05 2024-08-05 0001648087 us-gaap:SubsequentEventMember AREB:AccreditedInvestorOneMember AREB:RevenueAgreementMember 2024-08-05 2024-08-05 0001648087 us-gaap:SubsequentEventMember AREB:AccreditedInvestorTwoMember AREB:RevenueAgreementMember 2024-08-05 2024-08-05 0001648087 us-gaap:SubsequentEventMember AREB:AccreditedInvestorOneMember AREB:RevenueInterestPurchaseAgreementsMember 2024-08-05 2024-08-05 0001648087 us-gaap:SubsequentEventMember AREB:AccreditedInvestorTwoMember AREB:RevenueInterestPurchaseAgreementsMember 2024-08-05 2024-08-05 0001648087 us-gaap:SubsequentEventMember AREB:OneCorporateAccreditedInvestorMember AREB:RevenueInterestPurchaseAgreementsMember 2024-08-05 2024-08-05 0001648087 us-gaap:SubsequentEventMember AREB:SecuritiesPurchaseAgreementMember AREB:ThousandEightHundredDiagonalLendingLLCMember 2024-08-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

for the quarterly period ended June 30, 2024

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

for the transition period from ___ to ___

 

Commission file number 001-41267

 

AMERICAN REBEL HOLDINGS, INC.
(Exact name of registrant as specified in its charter)

 

Nevada   47-3892903

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

5115 Maryland Way, Suite 303

Brentwood, Tennessee

  37027
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (833) 267-3235

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   AREB   The Nasdaq Stock Market LLC
Common Stock Purchase Warrants   AREBW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in rule 12b-2 of the Exchange Act). Yes ☐ No

 

The number of shares of the registrant’s common stock outstanding as of August 14, 2024, was 8,406,729 shares, which includes 67,723 shares of common stock authorized but unissued as of this date.

 

 

 

 

 

 

AMERICAN REBEL HOLDINGS, INC.

INDEX TO QUARTERLY REPORT ON FORM 10-Q

 

    Page No.
PART I. FINANCIAL INFORMATION 3
     
Item 1. Interim Condensed Consolidated Financial Statements (unaudited) 3
     
  Condensed Consolidated Balance Sheets of American Rebel Holdings, Inc. at June 30, 2024 (unaudited) and December 31, 2023 (audited) 3
     
  Condensed Consolidated Statements of Operations of American Rebel Holdings, Inc. for the three months and six months ended June 30, 2024 and 2023 (unaudited) 4
     
  Condensed Consolidated Statements of Stockholders Equity (Deficit) of American Rebel Holdings, Inc. for the three and six months ended June 30, 2024 and 2023 (unaudited) 6
     
  Condensed Consolidated Statements of Cash Flows of American Rebel Holdings, Inc. for the six months ended June 30, 2024 and 2023 (unaudited) 8
     
  Notes to the Condensed Financial Statements (unaudited) 9
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 29
     
Item 3. Quantitative and Qualitative Disclosures about Market Risk 45
     
Item 4. Controls and Procedures 45
     
PART II. OTHER INFORMATION 46
     
Item 1. Legal Proceedings 46
     
Item 1A. Risk Factors 46
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 46
     
Item 3. Defaults Upon Senior Securities 46
     
Item 4. Mine Safety Disclosure 47
     
Item 5. Other Information 47
     
Item 6. Exhibits 48
     
Signatures 50

 

2
 

 

Part I. Financial Information

 

Item 1.- Interim Condensed Consolidated Financial Statements (unaudited)

 

AMERICAN REBEL HOLDINGS, INC.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

 

   June 30, 2024   December 31, 2023 
       (audited) 
ASSETS          
           
CURRENT ASSETS:          
Cash and cash equivalents  $452,785   $1,147,696 
Accounts receivable   2,143,808    2,816,541 
Prepaid expense   191,605    190,933 
Inventory   6,357,118    5,787,993 
Inventory deposits   315,084    315,083 
Total Current Assets   9,460,400    10,258,246 
           
Property and Equipment, net   310,776    360,495 
           
OTHER ASSETS:          
Lease deposits and other   78,954    83,400 
Right-of-use lease assets   1,312,831    1,946,567 
Goodwill   2,000,000    2,000,000 
Total Other Assets   3,391,785    4,029,967 
           
TOTAL ASSETS  $13,162,961   $14,648,708 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)          
           
CURRENT LIABILITIES:          
Accounts payable and other payables  $2,452,588   $1,978,768 
Accrued expenses   413,160    271,076 
Loans – Officer – related parties   260,793    45,332 
Loan – Director – related party   480,000    - 
Loans – Working capital   3,731,790    1,954,214 
Line of credit   1,992,129    1,456,929 
Right-of-use lease liabilities, current   791,222    1,039,081 
Total Current Liabilities   10,121,682    6,745,400 
           
Right-of-use lease liabilities, long-term   521,609    907,486 
           
TOTAL LIABILITIES   10,643,291    7,652,886 
           
STOCKHOLDERS’ EQUITY (DEFICIT):          
Preferred stock, $0.001 par value; 10,000,000 shares authorized; 333,000, and 200,000 issued and outstanding, respectively at June 30, 2024 and December 31, 2023   -      
Series A Preferred Shares, 150,000 shares authorized; 125,000 and 125,000 issued and outstanding, respectively, at June 30, 2024 and December 31, 2023   125    125 
Series B Preferred Shares, 350,000 shares authorized; 75,143 and 75,143 issued and outstanding, respectively, at June 30, 2024 and December 31, 2023   75    75 
Series D Preferred Shares, 500,000 shares authorized; 133,334 and nil issued and outstanding, respectively, at June 30, 2024 and December 31, 2023   133    - 
Common Stock, $0.001 par value; 600,000,000 shares authorized; 5,879,920 issued and outstanding at June 30, 2024 and December 31, 2023   5,880    5,880 
Additional paid in capital   55,681,333    52,203,336 
Accumulated deficit   (53,167,876)   (45,213,594)
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT)   2,519,670    6,995,822 
           
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)  $13,162,961   $14,648,708 

 

See Notes to Financial Statements.

 

3
 

 

AMERICAN REBEL HOLDINGS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

   For the
three months ended
June 30, 2024
   For the
three months ended
June 30, 2023
 
Revenue  $3,255,393   $3,670,571 
Cost of goods sold   3,224,738    2,982,688 
Gross margin   30,655    687,883 
           
Expenses:          
Consulting/payroll and other costs   445,166    828,520 
Compensation expense – officers – related party   212,500    102,985 
Compensation expense – officers – deferred comp – related party   1,344,125    - 
Rental expense, warehousing, outlet expense   80,515    275,474 
Product development costs   337,771    - 
Marketing and brand development costs   299,655    172,617 
Administrative and other   1,228,163    833,851 
Depreciation and amortization expense   30,681    25,275 
Operating expense   3,978,576    2,238,722 
Operating income (loss)   (3,947,921)   (1,550,839)
           
Other Income (Expense)          
Interest expense, net   (1,055,282)   (148,437)
Interest income   199    - 
Employee retention credit funds, net of costs to collect   -    1,107,672 
Gain/(loss) on settlement of debt instrument   (250,000)   - 
Gain/(loss) on sale of equipment   -    1,400 
Nonoperating income (expense)   (1,305,083)   960,635 
           
Net income (loss) before income tax provision   (5,253,004)   (590,204)
Provision for income tax   -    - 
Net income (loss)  $(5,253,004)  $(590,204)
Basic and diluted income (loss) per share  $(0.89)  $(0.87)
Weighted average common shares outstanding - basic and diluted   5,879,920    679,000 

 

See Notes to Financial Statements.

 

4
 

 

AMERICAN REBEL HOLDINGS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

   For the
six months ended
June 30, 2024
   For the
six months ended
June 30, 2023
 
Revenue  $7,299,230   $8,072,670 
Cost of goods sold   6,427,252    5,774,014 
Gross margin   871,978    2,298,656 
           
Expenses:          
Consulting/payroll and other costs   997,079    1,684,846 
Compensation expense – officers – related party   425,000    191,258 
Compensation expense – officers – deferred comp – related party   2,478,125    - 
Rental expense, warehousing, outlet expense   232,181    502,134 
Product development costs   436,400    16,495 
Marketing and brand development costs   564,710    425,342 
Administrative and other   1,908,677    1,195,000 
Depreciation and amortization expense   54,996    54,365 
Operating expense   7,097,168    4,069,440 
Operating income (loss)   (6,225,190)   (1,770,784)
           
Other Income (Expense)          
Interest expense, net   (1,479,141)   (155,547)
Interest income   711    - 
Employee retention credit funds, net of costs to collect   -    1,107,672 
Gain/(loss) on settlement of debt instrument   

(250,000

)   - 
Gain/(loss) on sale of equipment   (662)   1,400 
Nonoperating income (expense)   (1,729,092)   953,525 
           
Net income (loss) before income tax provision   (7,954,282)   (817,259)
Provision for income tax   -    - 
Net income (loss)  $(7,954,282)  $(817,259)
Basic and diluted income (loss) per share  $(1.35)  $(1.21)
Weighted average common shares outstanding - basic and diluted   5,879,920    678,000 

 

See Notes to Financial Statements.

 

5
 

 

AMERICAN REBEL HOLDINGS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY/(DEFICIT)

 

   Common
Stock
   Common
Stock
Amount
   Preferred
Stock
Amount
   Additional
Paid-in
Capital
   Accumulated
Deficit
   Total 
                         
Balance – March 31, 2023   677,221   $677   $175   $45,465,077   $(34,339,865)  $11,126,064 
                               
Sale of common stock   71,499    72    -    312,380    -    312,452 
Sale of 615,000 pre-funded common stock warrants $4.36 per share, exercise price of $0.01 per share   -    -    -    2,681,400    -    2,681,400 
Pre-funded common stock warrant offering costs and fees   -    -    -    (529,324)   -    (529,324)
Effect of reverse stock split – round lot shares of 2,093,591   2,093,591    2,094    -    -    -    - 
Post quarter effectuation of round lot share issuance   (2,093,591)   (2,094)   -    -    -    - 
Net loss for the three months ending June 30, 2023   -    -    -    -    (590,204)   (590,204)
                               
Balance – June 30, 2023   748,720   $749   $175   $47,929,533   $(34,930,069)  $13,000,388 
                               
Balance – March 31, 2024   5,879,920   $5,880   $200   $53,337,336   $(47,914,872)  $5,428,544 
                               
                               
Compensation component of vested and non-vested common stock equivalents attributable to Series A preferred stock – three (3) related parties   -    -    -    1,344,125    -    1,344,125 
Issuance of Series D preferred stock through the settlement and conversion of an original Revenue Interest Purchase note payable of $500,000 and $250,005 in accrued interest and $250,000 premium payment as inducement to settle   -    -    133    999,872    -    1,000,005 
Net loss for the three months ending June 30, 2024   -    -    -    -    (5,253,004)   (5,253,004)
                               
Balance – June 30, 2024   5,879,920   $5,880   $333   $55,681,333   $(53,167,876)  $2,519,670 

 

See Notes to Financial Statements.

 

6
 

 

AMERICAN REBEL HOLDINGS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY/(DEFICIT)

 

   Common
Stock
   Common
Stock
Amount
   Preferred
Stock
Amount
   Additional
Paid-in
Capital
   Accumulated
Deficit
   Total 
                         
Balance – December 31, 2022 (audited)   677,221   $677   $175   $45,465,077   $(34,112,810)  $11,353,119
                               
Sale of common stock   71,499    72    -    312,380    -    312,452 
Sale of 615,000 pre-funded common stock warrants $4.36 per share, exercise price of $0.01 per share   -    -    -    2,681,400    -    2,681,400 
Pre-funded common stock warrant offering costs and fees   -    -    -    (529,324)   -    (529,324)
Effect of reverse stock split – round lot shares of 2,093,591   2,093,591    2,094    -    -    -    - 
Post quarter effectuation of round lot share issuance   (2,093,591)   (2,094)   -    -    -    - 
Net loss for the six months ending June 30, 2023   -    -    -    -    (817,259)   (817,259)
                               
Balance – June 30, 2023   748,720   $749   $175   $47,929,533   $(34,930,069)  $13,000,388 
                               
Balance – December 31, 2023 (audited)   5,879,920   $5,880   $200   $52,203,336   $(45,213,594)  $6,995,822 
                               
Compensation component of vested and non-vested common stock equivalents attributable to Series A preferred stock – three (3) related parties   -    -    -    2,478,125    -    2,478,125 
Issuance of Series D preferred stock through the settlement and conversion of an original Revenue Interest Purchase note payable of $500,000 and $250,005 in accrued interest and $250,000 premium payment as inducement to settle   -    -    133    999,872    -    1,000,005 
Net loss for the six months ending June 30, 2024   -    -    -    -    (7,954,282)   (7,954,282)
                               
Balance – June 30, 2024   5,879,920   $5,880   $333   $55,681,333   $(53,167,876)  $2,519,670 

 

See Notes to Financial Statements.

 

7
 

 

AMERICAN REBEL HOLDINGS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

 

   For the
six months ended
June 30, 2024
   For the
six months ended
June 30, 2023
 
         
CASH FLOW FROM OPERATING ACTIVITIES:          
Net income (loss)  $(7,954,282)  $(817,259)
Depreciation and amortization   54,996    54,365 
(Gain)/loss on sale of equipment   662    (1,400)
Loss on settlement of debt   

250,000

    - 
Settlement of revenue interest purchase note through the issuance of preferred stock   750,005    - 
Recognition of deferred compensation attributable to convertibility of Series A preferred stock issued to three (3) related parties   2,478,125    - 
Adjustments to reconcile net loss to cash (used in) operating activities:          
Accounts receivable   672,733    (368,993)
Prepaid expenses   3,774    46,756 
Inventory, deposits and other   (569,126)   (1,153,758)
Accounts payable   473,820    (234,630)
Accrued expenses   142,084    - 
Net Cash (Used in) Operating Activities   (3,697,209)   (2,474,919)
           
CASH FLOW FROM INVESTING ACTIVITIES:          
Disposition/(purchase) of fixed assets, net   (5,939)   1,402 
Net Cash Provided by Investing Activities   (5,939)   1,402 
           
CASH FLOW FROM FINANCING ACTIVITIES:          
Proceeds from the sale of common stock, net of offering costs   -    312,452 
Proceeds from the sale of prefunded warrants, net of offering costs   -    2,152,076 
Proceeds from initial drawdown of line of credit   -    1,700,000 
Proceeds from line of credit, net of payments   535,200    (340,317)
Proceeds from loans – officer - related parties, net   215,461    146,000 
Proceeds from loan – director - related party, net   400,000    - 
Proceeds from working capital loans   2,091,503    1,000,000 
Principal payments on working capital loans   (233,927)   (120,195)
Net Cash Provided by Financing Activities   3,008,237    4,850,016 
           
           
CHANGE IN CASH   (694,911)   2,376,499 
           
CASH AT BEGINNING OF PERIOD   1,147,696    356,754 
           
CASH AT END OF PERIOD  $452,785   $2,733,253 
           
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION          
Cash paid for:          
Interest  $281,666   $156,252 
Income taxes  $-   $- 
           
Non-cash investing and financing activities:          
Note payable principal and interest associated with revenue interest purchase conversion - Series D preferred stock  $1,000,005   $- 
Notes payable - related party principal increase from assessed interest obligations  $80,000   $- 
Notes payable principal increase from assessed interest obligations  $1,189,795   $- 

 

See Notes to Financial Statements.

 

8
 

 

AMERICAN REBEL HOLDINGS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024

(unaudited)

 

NOTE 1 – ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Organization

 

The Company was incorporated on December 15, 2014, under the laws of the State of Nevada, as CubeScape, Inc. Effective January 5, 2017, the Company amended its articles of incorporation and changed its name to American Rebel Holdings, Inc. On June 19, 2017, the Company completed a business combination with its majority stockholder, American Rebel, Inc. As a result, American Rebel, Inc. became a wholly-owned subsidiary.

 

Nature of Operations

 

The Company develops and sells branded products in the beverage, self-defense, safe storage and other patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well e-commerce and television. The Company’s products are marketed under the American Rebel Brand and are proudly imprinted with such branding. Through its “Champion Entities” (which consists of Champion Safe Co., Inc., Superior Safe, LLC, Safe Guard Security Products, LLC, and Champion Safe De Mexico, S.A. de C.V.) the Company promotes and sells its safe and storage products through a growing network of dealers, in select regional retailers and local specialty safe, sporting goods, hunting and firearms retail outlets, as well as through online avenues, including website and e-commerce platforms. The Company sells its products under the Champion Safe Co., Superior Safe Company and Safe Guard Safe Co. brands as well as the American Rebel Brand. On August 9, 2023, the Company entered into a Master Brewing Agreement (the “Brewing Agreement”) with Associated Brewing Company, a Minnesota limited liability company (“Associated Brewing”). Under the terms of the Brewing Agreement, Associated Brewing has been appointed as the exclusive producer and seller of American Rebel branded spirits, with the initial product being the American Rebel Light Beer (“American Rebel Beer”). We established American Rebel Beverages, LLC as a wholly-owned subsidiary to hold our licenses with respect to the beer business. American Rebel Beer launched regionally in 2024.

 

To varying degrees, the development of geopolitical conflicts, supply chain disruptions, government actions to slow rapid inflation in recent years and predictable sales cycles have produced varying effects on our business. The economic effects from these events over the long term cannot be reasonably estimated at this time. Accordingly, estimates used in the preparation of our financial statements, including those associated with the evaluation of certain long-lived assets, goodwill and other intangible assets for impairment, expected credit losses on amounts owed to us (through accounts receivable) and the estimations of certain losses assumed under warranty and other liability contracts, may be subject to significant adjustments in future periods.

 

Interim Financial Statements and Basis of Presentation

 

The accompanying unaudited interim financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the rules and regulations of the SEC set forth in Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by the U.S. GAAP for complete financial statements. The unaudited interim financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented. Unaudited interim results are not necessarily indicative of the results for the full fiscal year. These financial statements should be read along with the Annual Report filed on Form 10-K of the Company for the period ended December 31, 2023, and notes thereto contained, filed on April 12, 2024.

 

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, American Rebel, Inc., American Rebel Beverages, LLC, and the Champion Entities. All significant intercompany accounts and transactions have been eliminated.

 

Year-end

 

The Company’s year-end is December 31.

 

9
 

 

Cash and Cash Equivalents

 

For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. The carrying value of these investments approximates fair value.

 

Inventory and Inventory Deposits

 

Inventory consists of beer, backpacks, jackets, safes, other storage products and accessories manufactured to our design and held for resale and are carried at the lower of cost (First-in, First-out Method) or net realizable value. The Company determines an estimate for the reserve of slow moving or obsolete inventories by regularly evaluating individual inventory levels, projected sales and current economic conditions. The Company makes deposit payments on certain inventory to be manufactured that are carried separately until the manufactured goods are received into inventory.

 

Fixed Assets and Depreciation

 

Property and equipment are stated at cost, net of accumulated depreciation. Additions and improvements are capitalized while ordinary maintenance and repair expenditures are charged to expense as incurred. Depreciation is recorded using the straight-line method over the estimated useful life of the asset, which ranges from five to seven years.

 

Revenue Recognition

 

In accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers, revenues are recognized when control of the promised goods or services is transferred to our clients, in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods and services. To achieve this core principle, we apply the following five steps: (1) Identify the contract with a client; (2) Identify the performance obligations in the contract; (3) Determine the transaction price; (4) Allocate the transaction price to performance obligations in the contract; and (5) Recognize revenues when or as the company satisfies a performance obligation.

 

These steps are met when an order is received, a price is agreed to, and the product is shipped or delivered to that customer.

 

The following table sets forth the approximate percentage of revenue by primary category: 

 

Percentage of revenue  2024   2023   2024   2023 
   For the three months ended June 30,   For the six months ended June 30, 
Percentage of revenue  2024   2023   2024   2023 
Safes   98.7%   98.8%   99.2%   98.6%
Soft goods   0.6%   1.2%   0.5%   1.4%
Beverages   0.7%   0.0%   0.3%   0.0%
Total   100%   100%   100%   100%

 

Accounts receivable totaled $2,143,808 and $2,816,541 as of June 30, 2024 and December 31, 2023, respectively.

 

The carrying amount of accounts receivables is reduced by a valuation allowance for expected credit losses, as necessary, that reflects management’s best estimate of the amount that will not be collected. This estimation takes into consideration historical experience, current conditions and, as applicable, reasonable supportable forecasts. Actual results could vary from the estimate. Accounts are charged against the allowance when management deems them to be uncollectible. The allowance for doubtful accounts was not material as of June 30, 2024 and December 31, 2023.

 

Advertising Costs

 

Advertising costs are expensed as incurred; Marketing costs which we consider to be advertising costs incurred were $299,655 and $172,617 for the three-month and $564,710 and $425,342 for the six-month periods ended June 30, 2024, and 2023, respectively.

 

Convertible Promissory Notes

 

The Company accounts for convertible promissory notes under ASC Topic 815, Derivatives and Hedging (“ASC 815”). Under ASC 815-15-25, the election can be made at the inception of a financial instrument to account for the instrument under the fair value option under ASC 815. The Company has not made any such elections for its promissory notes that may be convertible in the event of default (see Note 7 – Notes Payable – Working Capital). Using fair value option, the convertible promissory note would be required to be recorded at its initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the notes are recognized as non-cash change in the fair value of the convertible promissory note in the condensed consolidated statements of operations. The fair value of the option to convert into common stock would be valued utilizing either the Monte Carlo model or Black Scholes pricing model.

 

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the condensed consolidated statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the condensed consolidated balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

 

Fair Value of Financial Instruments

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of June 30, 2024, and December 31, 2023, respectively. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values. These financial instruments include cash, accounts receivable, and accounts payable, and the line of credit. Fair values were assumed to approximate carrying values for cash and payables because they are short term in nature and their carrying amounts approximate fair values or they are payable on demand.

 

Fair value is defined as the exchange value that would be received on the measurement date to sell an asset or to value the amount paid to transfer a liability in the principal or most advantageous market available to the entity in an orderly transaction between market participants. The three levels of the fair value hierarchy are as follows:

 

Level 1: Inputs are unadjusted quoted market prices in active markets for identical assets or liabilities that the entity has the ability to access at the measurement date. Level 1 inputs provide the most reliable measure of fair value as of the measurement date.

 

10
 

 

Level 2: Inputs are based on significant observable inputs, including unadjusted quoted market prices for similar assets and liabilities in active markets, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability.

 

Level 3: Inputs are significant unobservable inputs for the asset or liability.

 

The level of the fair value hierarchy within which the fair value measurement in its entirety falls is based on the lowest level input that is significant to the fair value measurement in its entirety.

 

Stock-Based Compensation

 

The Company records stock-based compensation in accordance with the guidance in ASC Topic 505 and 718 which requires the Company to recognize expense related to the fair value of its employee stock option awards. This eliminates accounting for share-based compensation transactions using the intrinsic value and requires instead that such transactions be accounted for using a fair-value-based method. The Company recognizes the cost of all share-based awards on a graded vesting basis over the vesting period of the award.

 

The Company accounts for equity instruments issued in exchange for the receipt of goods or services from other than employees in accordance with ASC 718-10 and the conclusions reached ASC 505-50. Costs are measured at the estimated fair market value of the consideration received or the estimated fair value of the equity instruments issued, whichever is more reliably measurable. The value of equity instruments issued for consideration other than employee services is determined on the earliest of a performance commitment or completion of performance by the provider of goods or services as defined by ASC 505-50.

 

Net Loss per Share

 

Net loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as defined by ASC 260, Earnings per Share. Basic losses per common share (“EPS”) calculations are determined by dividing net loss by the weighted average number of shares of common stock outstanding during the year. Diluted loss per common share calculations are determined by dividing net loss by the weighted average number of common shares and dilutive common share equivalents outstanding. Dilutive common share equivalents are negligible or immaterial as dilutive shares to be issued during net loss years were non-existent. For the three months and six months ended June 30, 2024, and June 30, 2023, net loss per share was $(0.89) and $(0.87) (for 2024), and $(1.35) and $(1.21) (for 2023), respectively.

 

Fully diluted shares outstanding is the total number of shares that the Company would theoretically have if all dilutive securities were exercised and converted into shares. Dilutive securities include options, warrants, convertible debt, preferred stock and anything else that can be converted into shares. Potential dilutive shares consist of the incremental common shares issuable upon the exercise of dilutive securities, calculated using the treasury stock method. The calculation of dilutive shares outstanding excludes out-of-the-money options (i.e., such options’ exercise prices were greater than the average market price of our common shares for the period) because their inclusion would have been antidilutive. In periods of losses, diluted loss per share is computed on the same basis as basic loss per share as the inclusion of any other potential shares outstanding would be anti-dilutive.

 

Income Taxes

 

The Company follows ASC Topic 740 for recording provision for income taxes. Deferred tax assets and liabilities are computed based upon the difference between the financial statement and income tax basis of assets and liabilities using the enacted marginal tax rate applicable when the related asset or liability is expected to be realized or settled. Deferred income tax expense or benefit is based on the changes in the asset or liability for each period. If available evidence suggests that it is more likely than not that some portion or the entire deferred tax asset will not be realized, a valuation allowance is required to reduce the deferred tax asset to the amount that is more likely than not to be realized. Future changes in such valuation allowance are included in the provision for deferred income tax in the period of change.

 

Deferred income tax may arise from temporary differences resulting from income and expense items reported for financial accounting and tax purposes in different periods. Deferred taxes are classified as current or non-current, depending on the classification of assets and liabilities to which they relate. Deferred taxes arising from temporary differences that are not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse.

 

11
 

 

The Company applies a more-likely-than-not recognition threshold for all tax uncertainties. ASC Topic 740 only allows the recognition of tax benefits that have a greater than fifty percent likelihood of being sustained upon examination by taxing authorities. As of June 30, 2024, and December 31, 2023, the Company reviewed its tax positions and determined there were no outstanding, or retroactive tax positions with less than a 50% likelihood of being sustained upon examination by the taxing authorities, therefore this standard has not had a material effect on the Company.

 

The Company classifies tax-related penalties and net interest as income tax expense. For the three and six-month periods ended June 30, 2024, and 2023, respectively, no income tax benefit has been recorded due to the recognition of a full valuation allowance.

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates.

 

Warranties

 

The Company’s safe manufacturing business estimates its exposure to warranty claims based on both current and historical (with respect to the Champion Entities) product sales data and warranty costs (actual) incurred. The Company assesses the adequacy of its recorded warranty liability each quarter and adjusts the amount as necessary. Warranty liability is included in our accrued expense accounts in the accompanying condensed consolidated balance sheets. We estimate that the warranty liability is nominal or negligible based on the superior quality of products and our excellent customer relationships. Warranty liability recorded as of June 30, 2024 and December 31, 2023 was approximately $85,000 and $82,238, respectively.

 

Right of Use Assets and Lease Liabilities

 

ASC 842, Leases requires lessees to recognize almost all leases on the balance sheet as a Right-of-use (“ROU”) asset and a lease liability and requires leases to be classified as either an operating or a finance type lease. The standard excludes leases of intangible assets or inventory. The Company elected the practical expedient related to treating lease and non-lease components as a single lease component for all equipment leases as well as electing a policy exclusion permitting leases with an original lease term of less than one year to be excluded from the ROU assets and lease liabilities.

 

Under ASC 842, the Company determines if an arrangement is a lease at inception. ROU assets and liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of the Company’s leases do not provide an implicit rate, the Company estimated the incremental borrowing rate in determining the present value of lease payments. The ROU asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options.

 

Operating leases are included in operating lease Right-of-use assets and operating lease liabilities, current and non-current, on the Company’s condensed consolidated balance sheets.

 

Recent Pronouncements

 

The Company evaluated recent accounting pronouncements through June 30, 2024, and believes that none have a material effect on the Company’s financial statements.

 

12
 

 

Concentration Risks

 

Prior to the closing of the Champion Entities in 2022, the Company purchased a substantial portion (over 20%) of its inventory from two third-party vendors. With the closing of the Champion Entities, the Company no longer purchases a substantial portion (over 20%) of its inventory from these third-party vendors. As of June 30, 2024 and December 31, 2023, the net amount due to these third-party vendors (accounts payable and accrued expense) was $0.

 

Reclassifications

 

Certain prior period amounts have been reclassified to conform to the current period presentation.

 

NOTE 2 – GOING CONCERN

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business. As noted above, the Company is in the growth and acquisition stage and, accordingly, has not yet reached profitability from its operations. Since inception, the Company has been engaged in financing activities and executing its plan of operations and incurring costs and expenses related to product development, branding, inventory buildup and product launch. As a result, the Company has continued to incur significant net losses for the six months ended June 30, 2024, and 2023 of ($7,954,282) and ($817,259), respectively. The Company’s accumulated deficit was ($53,167,876) as of June 30, 2024, and ($45,213,594) as of December 31, 2023. The Company’s working capital was $129,940 as of June 30, 2024, compared to $4,551,927 as of December 31, 2023.

 

The ability of the Company to continue as a going concern is dependent upon its ability to raise capital from the sale of its equity and, ultimately, the achievement of significant operating revenues and profitability. The Company is currently conducting a Reg. A+ offering on Form 1-A that became effective on March 13, 2024. Total amount to be sought under this Reg. A+ offering is approximately $20.0 million. The Company due to its notification and termination of its prior PCAOB accountants is required to re-audit its financial statements for the past two years for inclusion in the Reg. A+ offering documents. Until that time that the financial statements are re-audited and opined on by its new PCAOB accountants it is not able to intake any of the proceeds committed to the offering.

 

Management believes that sufficient funding can be secured through the obtaining of loans, as well as future offerings of its preferred and common stock. However, no assurance can be given that the Company will obtain this additional working capital, or if obtained, that such funding will not cause substantial dilution to its existing stockholders. As indicated in our footnotes to our consolidated financial statements, most of our current debt instruments are charging high interest rates. These interest payments and/or premium repayments and prepayments may make it difficult for us to enter into new debt agreements. If the Company is unable to secure such additional funds from these sources, it may be forced to change or delay some of its business objectives and efforts. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern.

 

These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

NOTE 3 – INVENTORY AND DEPOSITS

 

Inventory and deposits include the following:

  

   June 30, 2024   December 31, 2023 
   (unaudited)   (audited) 
Inventory – Finished Goods and Work in Progress  $4,348,031   $4,017,381 
Inventory – Raw Materials   2,009,087    1,770,612 
Total Inventory  $6,357,118   $5,787,993 

 

The Company accounts for excess or obsolete inventory with a reserve that is established based on management’s estimates of the net realizable value of the related products. These reserves are product specific and are based upon analyses of product lines that are slow moving or expected to become obsolete due to significant product enhancements.

 

Included in inventory – finished goods and work in progress is approximately $60,000 in finished products related to our American Rebel branded beer lager as of June 30, 2024. This inventory is immediately available to the consumer and for distribution. During the three and six-month periods ended June 30, 2024 we wrote off approximately $180,000 and $180,000, respectively, of this finished product branded beer lager inventory. This is considered a one-time event.

 

When inventory is physically disposed of, we account for the write-offs by making a debit to the reserve and a credit to inventory for the standard cost of the inventory item. Our valuation reserve is applied as an estimate to specific product lines. Since the inventory item retains its standard cost until it is either sold or written off, the reserve estimates will differ from the actual write-off. There were no other material write-offs or inventory reserves during the three and six-months ended June 30, 2024 and 2023 other than what is described above with respect to our branded beer lager.

 

13
 

 

NOTE 4 – PROPERTY AND EQUIPMENT

 

Property and equipment include the following:

  

   June 30, 2024   December 31, 2023 
   (unaudited)   (audited) 
Plant, property and equipment  $375,316   $353,885 
Vehicles   398,121    435,153 
Property and equipment gross   773,437    789,038 
Less: Accumulated depreciation   (462,661)   (428,543)
Net property and equipment  $310,776   $360,495 

 

For the three-month and six-month periods ended June 30, 2024 and 2023 we recognized $30,681 and $25,275, and $54,996 and $54,365 in depreciation expense, respectively. We depreciate these assets over a period of 57 years, which has been deemed their useful life.

 

NOTE 5 – RELATED PARTY NOTES PAYABLE AND RELATED PARTY TRANSACTIONS

 

Charles A. Ross, Jr. serves as the Company’s Chief Executive Officer. Compensation for Mr. Ross was $86,154 and $60,000 plus stock awards (granted and issued) of $0 and $0, respectively for the three months ended June 30, 2024 and 2023 and $162,500 and $120,000 plus stock awards (granted and issued) of $0 and $0, respectively for the six months ended June 30, 2024 and 2023. Doug E. Grau serves as the Company’s President and Interim Principal Accounting Officer. Compensation for Mr. Grau was $70,000 and $30,000 plus stock awards (granted and issued) of $0 and $0, respectively for the three months ended June 30, 2024 and 2023 and $132,500 and $70,000 plus stock awards (granted and issued) of $0 and $0, respectively for the six months ended June 30, 2024 and 2023.

 

Both Messrs. Ross and Grau serve as the Company’s Chief Executive Officer and President, respectively. Compensation for both, Messrs. Ross and Grau, includes a base salary and a bonus based upon certain performance measures approved by the board of directors. Three of our officers lent the Company approximately $260,793, net of repayments during the six months ended June 30, 2024, the loans are unsecured non-interest-bearing demand notes. These officers provided these loans as short-term funding and usually receives repayment a few months later, pending working capital needs.

 

Corey Lambrecht serves as the Company’s Chief Operating Officer. Mr. Lambrecht and the Company entered into an employment agreement on November 20, 2023. Mr. Lambrecht’s employment agreement provides for an initial annual base salary of $260,000, which may be adjusted by the board of directors of the Company. Mr. Lambrecht at this time continues as a director but ceased being an independent director of the Company. Mr. Lambrecht received approximately $130,000 and $0 for his services as an officer of the Company for six months ended June 30, 2024, and $45,000 as an independent consultant for the Company for the six months ended June 30, 2023, respectively.

 

The Company in connection with its employment agreements, as amended, reserved for issuance of 62,500,000 shares of its common stock that are convertible under the Series A preferred stock conversion terms.

 

Per Mr. Lambrecht’s employment agreement entered into on November 20, 2023, the share-award grant is to vest 1/4th upon the signing of Mr. Lambrecht’s employment, another 1/4th on January 1, 2024, another 1/4th on January 1, 2025 and the remaining 1/4th on January 1, 2026. Mr. Lambrecht’s employment agreement has a term running from November 20, 2023 through December 31, 2026, a term of 37 and ½ months. The Company on November 20, 2023 for Mr. Lambrecht recognized $4,612,500 as a total value for the share-award grant and $246,000 in compensation expense for the 4th quarter of 2023 for the share award grant and respective earn-outs of the common stock equivalents underlying that share award. For the six months ended June 30, 2024 the Company recognized an additional $1,007,334 in compensation expense attributable to the share award grant and respective earn-out. On January 1, 2024 another 6,250 shares of Series A preferred stock vested for Mr. Lambrecht, providing for a total of 6,250,000 of shares of common stock that Mr. Lambrecht may convert his Series A preferred shares into.

 

Per Mr. Ross’s amended employment agreement with an effective date of November 20, 2023, the already issued or existing share-award grant is to vest 1/5th on January 1, 2024, another 1/5th on January 1, 2025, 1/5th on January 1, 2026, 1/5th on January 1, 2027 and the remaining 1/5th on January 1, 2028. Mr. Ross’s amended employment agreement has an effective term running from November 20, 2023 through December 31, 2026, a term of 37 and ½ months. The Company on October 31, 2023 for Mr. Ross recognized $8,752,500 as a total value for the share-award grant and recognized $466,800 in compensation expense for the 4th quarter of 2023 for the share award grant and respective earn-outs of the common stock equivalents underlying that share award. For the six months ended June 30, 2024 the Company recognized an additional $2,079,834 in compensation expense attributable to the share award grant and respective earn-out. On January 1, 2024 10,000 shares of Series A preferred stock vested for Mr. Ross, providing for a total of 5,000,000 of shares of common stock that Mr. Ross may convert his Series A preferred shares into at any time.

 

14
 

 

Per Mr. Grau’s amended employment agreement with an effective date of November 20, 2023, the already issued or existing share-award grant is to vest 1/5th on January 1, 2024, another 1/5th on January 1, 2025, 1/5th on January 1, 2026, 1/5th on January 1, 2027 and the remaining 1/5th on January 1, 2028. Mr. Grau’s amended employment agreement has an effective term running from November 20, 2023 through December 31, 2026, a term of 37 and ½ months. The Company on October 31, 2023 for Mr. Grau recognized $8,752,500 as a total value for the share-award grant and recognized $466,800 in compensation expense for the 4th quarter of 2023 for the share award grant and respective earn-outs of the common stock equivalents underlying that share award. For the six months ended June 30, 2024 the Company recognized an additional $2,079,834 in compensation expense attributable to the share award grant and respective earn-out.

 

The Company in connection with various employment and independent directors’ agreements is required to issue shares of its common stock as payment for services performed or to be performed. The value of the shares issued is determined by the fair value of the Company’s common stock that trades on the Nasdaq Capital Market. This value on the date of grant is afforded to the Company for the recording of stock compensation to employees and other related parties or control persons and the recognition of this expense over the period in which the services were incurred or performed. Most of the Company’s agreement for stock compensation provide for services performed to have been satisfied by the initial grant, thereby incurring the cost immediately from the grant.

 

Stock-based compensation is presented in accordance with the guidance of ASC Topic 718, “Compensation – Stock Compensation” (“ASC 718”). Under the provisions of ASC 718, the Company is required to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our statements of operations. Where the stock-based compensation is not an award, option, warrant or other common stock equivalent, the Company values the shares based on fair value with respect to its grant date and the price that investors may have been paying for the Company’s common stock on that date in its various exempt private placement offerings.

 

Taxable value of the stock-based compensation is recorded in accordance with the Internal Revenue Service’s regulations as it pertains to employees, control persons and others whereby they receive share-based payments. This may not always align with what the Company records these issuances in accordance with GAAP. There are no provisional tax agreements or gross-up provisions with respect to any of our share-based payments to these entities. The payment or withholding of taxes is strictly left to the recipient of the share-based payments, or the modification of share-based payments.

 

   June 30, 2024   December 31, 2023 
   (unaudited)   (audited) 
Working capital loan with a director of the Company on June 28, 2024. The prepayment or purchase price prior to July 31, 2024 is 120.0% or $480,000, the prepayment or purchase price after July 31, 2024 and prior to August 31, 2024 is 125.0% or $500,000, thereafter the purchase price is $520,000 or 130.0% on or before September 30, 2024.   480,000    - 
           
Total recorded as a current liability  $480,000   $- 

  

On June 28, 2024, the Company entered into a short-term loan with a director, Lawrence Sinks (“Mr. Sinks”), evidenced by a promissory note in the principal amount of $400,000 (the “Director’s Note”). Proceeds from the Director’s Note are to be utilized solely by the Company’s wholly-owned subsidiary, American Rebel Beverages, LLC. The Director’s Note is due on September 30, 2024, with a repayment amount of $520,000. The Company may reduce the repayment amount to $500,000 if the Note is repaid on or before August 31, 2024.

 

NOTE 6 – LINE OF CREDIT – FINANCIAL INSTITUTION

 

During February 2023, the Company entered into a $2 million master credit agreement (credit facility) with Bank of America (“LOC”). The LOC accrues interest at a rate determined by the Bloomberg Short-Term Bank Yield Index (“BSBY”) Daily Floating Rate plus 2.05 percentage points (which at June 30, 2024 and December 31, 2023 for the Company was 7.45% and 7.48%, respectively), and is secured by all the assets of the Champion Entities. The LOC expired February 28, 2024. The outstanding amount due on the LOC at June 30, 2024 and December 31, 2023 was, respectively.

  

   June 30, 2024   December 31, 2023 
   (unaudited)   (audited) 
Line of credit from a financial institution.  $1,992,129   $1,456,929 
           
Total recorded as a current liability  $1,992,129   $1,456,929 

 

As of June 30, 2024 and December 31, 2023 the total balance due of $1,992,129 and $1,456,929 is reported as current as the LOC was to be repaid within one year, with subsequent drawdowns as needed by the Company. Upon inception the Company paid a one-time loan fee equal to 0.1% of the LOC amount available. In the likelihood of default, the default interest automatically increases to 6% over the BSBY plus an additional 2.05% rate.

 

15
 

 

Initially the Company drew down on the LOC in the amount of $1.7 million, with subsequent net payments and draws on the LOC. The Company during the first quarter of 2024 increased the LOC amount beyond its initial drawdown amount.

 

The maturity date on the LOC was initially extended by Bank of America to April 30, 2024. The balance at the maturity was approximately $1.9 million and access to the line of credit with Bank of America was terminated. The Company, through its wholly-owned subsidiary Champion, and Bank of America have continued meaningful dialogue and the Company is working with Bank of America regarding term loan repayment options for the original LOC.

 

NOTE 7 – NOTES PAYABLE – WORKING CAPITAL

 

   June 30, 2024   December 31, 2023 
   (unaudited)   (audited) 
Working capital loans with an irrevocable trust established in the state of Georgia, which assumed a previous loan held by a different limited liability company in the amount of $600,000 made on or about June 30, 2022. The two working capital loans are demand loans and accrue interest at 12% per annum with interest only payments that are due by the last day of the quarter. The 1st loan in the amount of $150,000 was due and payable on December 31, 2023 was partially repaid with the remaining $75,000 due on June 30, 2024, the 2nd loan in the amount of $300,000 is due and payable on June 30, 2024.    375,000    450,000 
Working capital loan agreement with a limited liability company domiciled in the state of Virginia. The working capital loan requires an initial payment of $162,667.20 on June 30, 2024 with six (6) additional payments of $18,074.14 on the 30th of each month following funding. The working capital loan is due and payable on December 31, 2024. The working capital loan has an effective interest rate of 35.4% without taking into account the 15% original issue discount charged upon entering into the loan. This working capital loan has a conversion right associated with it in the case of an Event of Default as that term is defined below. The conversion price subject to the conversion right allows the holder of the working capital loan to receive shares not subject to Rule 144 issued as full payment for principal and (all) accrued interest at a 25% discount to market, and that market price is the lowest trading price of the Company’s common stock during the ten (10) trading days prior to the notice of conversion by the holder. No Black Scholes calculation has been made with respect to the working capital loan as the Event of Default is highly unlikely. The holder of the working capital loan has required the Company to hold sufficient enough shares in reserve to satisfy the conversion at a factor of four (4) for one (1).   235,750    - 
Working capital loan agreement with a limited liability company domiciled in the state of Virginia. The working capital loan requires an initial payment of $13,881.78 on June 30, 2024 with eight (8) additional payments of $13,881.78 on the 30th of each month following funding. The working capital loan is due and payable on February 28, 2025. The working capital loan has an effective interest rate of 18.8% without taking into account the 12% original issue discount charged upon entering into the loan. This working capital loan has a conversion right associated with it in the case of an Event of Default as that term is defined below. The conversion price subject to the conversion right allows the holder of the working capital loan to receive shares not subject to Rule 144 issued as full payment for principal and (all) accrued interest at a 25% discount to market, and that market price is the lowest trading price of the Company’s common stock during the ten (10) trading days prior to the notice of conversion by the holder. No Black Scholes calculation has been made with respect to the working capital loan as the Event of Default is highly unlikely. The holder of the working capital loan has required the Company to hold sufficient enough shares in reserve to satisfy the conversion at a factor of four (4) for one (1).   111,550    - 
Working capital loan agreement with a limited liability company domiciled in the state of Delaware. The working capital loan requires an initial payment of $13,881.78 on June 30, 2024 with eight (8) additional payments of $13,881.78 on the 30th of each month following funding. The working capital loan is due and payable on February 28, 2025. The working capital loan has an effective interest rate of 18.8% without taking into account the 12% original issue discount charged upon entering into the loan. This working capital loan has a conversion right associated with it in the case of an Event of Default as that term is defined below. The conversion price subject to the conversion right allows the holder of the working capital loan to receive shares not subject to Rule 144 issued as full payment for principal and (all) accrued interest at a 25% discount to market, and that market price is the lowest trading price of the Company’s common stock during the ten (10) trading days prior to the notice of conversion by the holder. No Black Scholes calculation has been made with respect to the working capital loan as the Event of Default is highly unlikely. The holder of the working capital loan has required the Company to hold sufficient enough shares in reserve to satisfy the conversion at a factor of four (4) for one (1).   111,550    - 
Working capital loan agreement structured as a Revenue Interest Purchase Agreement (“revenue participation interest”) with a corporate entity domiciled in the state of California. The working capital loan provided for a purchase of an ownership interest in the revenues of our Champion subsidiary. The revenue participation interest requires payments of $75,000 per month (beginning on May 5, 2024) until the revenue participation interest is repurchased by the Company. The revenue participation interest is subject to a repurchase option by the Company. The repurchase price prior to April 1, 2024 is 125% or $625,000, the repurchase price after April 1, 2024 and prior to May 5, 2024 is 137.5% or $675,000, thereafter the repurchase price is $687,500 plus payments of $75,000 per month due on the fifth calendar day of each month until repurchased in its entirety. On May 13, 2024 the Company and the holder of the revenue participation interest entered into a settlement and conversion agreement whereby the Company issued Series D preferred stock as full satisfaction for the revenue participation interest loan.   -    500,000 
Working capital loan agreement structured as a Revenue Interest Purchase Agreement (“revenue participation interest”) with an individual domiciled in the state of California. The working capital loan provided for a purchase of an ownership interest in the revenues of our Champion subsidiary. The revenue participation interest requires payments of $10,000 per month (beginning on July 5, 2024) until the revenue participation interest is repurchased by the Company. The revenue participation interest is subject to a repurchase option by the Company. The repurchase price prior to May 31, 2024 is 140% or $140,000, the repurchase price after June 1, 2024 is 154% or $154,000, plus payments of $10,000 per month due on the fifth calendar day of each month until repurchased in its entirety. The repurchase price after June 1, 2024 is reduced by any amounts paid by the Company to the lender prior to that date. The Revenue Interest Purchase Agreement also requires the Company to make payments commencing after June 1, 2024 equal to 5.15% of the net proceeds received by the Company from the Regulation A Offering. In the event of default, the Company is obligated to pay an additional 25% of any and all amounts due, immediately.   154,000    - 
Working capital loan agreement structured as a Revenue Interest Purchase Agreement (“revenue participation interest”) with an individual domiciled in the state of California. The working capital loan provided for a purchase of an ownership interest in the revenues of our Champion subsidiary. The revenue participation interest requires payments of $10,000 per month (beginning on July 5, 2024) until the revenue participation interest is repurchased by the Company. The revenue participation interest is subject to a repurchase option by the Company. The repurchase price prior to May 31, 2024 is 140% or $140,000, the repurchase price after June 1, 2024 is 154% or $154,000, plus payments of $10,000 per month due on the fifth calendar day of each month until repurchased in its entirety. The repurchase price after June 1, 2024 is reduced by any amounts paid by the Company to the lender prior to that date. The Revenue Interest Purchase Agreement also requires the Company to make payments commencing after June 1, 2024 equal to 5.15% of the net proceeds received by the Company from the Regulation A Offering. In the event of default, the Company is obligated to pay an additional 25% of any and all amounts due, immediately.   154,000    - 
Working capital loan agreement structured as a Revenue Interest Purchase Agreement (“revenue participation interest”) with an individual domiciled in the state of California. The working capital loan provided for a purchase of an ownership interest in the revenues of our Champion subsidiary. The revenue participation interest requires payments of $10,000 per month (beginning on July 5, 2024) until the revenue participation interest is repurchased by the Company. The revenue participation interest is subject to a repurchase option by the Company. The repurchase price prior to May 31, 2024 is 140% or $140,000, the repurchase price after June 1, 2024 is 154% or $154,000, plus payments of $10,000 per month due on the fifth calendar day of each month until repurchased in its entirety. The repurchase price after June 1, 2024 is reduced by any amounts paid by the Company to the lender prior to that date. The Revenue Interest Purchase Agreement also requires the Company to make payments commencing after June 1, 2024 equal to 5.15% of the net proceeds received by the Company from the Regulation A Offering. In the event of default, the Company is obligated to pay an additional 25% of any and all amounts due, immediately.   154,000    - 
Working capital loan agreement structured as a Revenue Interest Purchase Agreement (“revenue participation interest”) with an individual domiciled in the state of California. The working capital loan provided for a purchase of an ownership interest in the revenues of our Champion subsidiary. The revenue participation interest requires payments of $7,500 per month (beginning on July 5, 2024) until the revenue participation interest is repurchased by the Company. The revenue participation interest is subject to a repurchase option by the Company. The repurchase price prior to May 31, 2024 is 140% or $105,000, the repurchase price after June 1, 2024 is 154% or $115,500, plus payments of $7,500 per month due on the fifth calendar day of each month until repurchased in its entirety. The repurchase price after June 1, 2024 is reduced by any amounts paid by the Company to the lender prior to that date. The Revenue Interest Purchase Agreement also requires the Company to make payments commencing after June 1, 2024 equal to 3.86% of the net proceeds received by the Company from the Regulation A Offering. In the event of default, the Company is obligated to pay an additional 25% of any and all amounts due, immediately.   115,500    - 
Working capital loan agreement structured as a Revenue Interest Purchase Agreement (“revenue participation interest”) with a limited liability company domiciled in the state of Colorado. The working capital loan provided for a purchase of an ownership interest in the revenues of our Champion subsidiary. The revenue participation interest requires payments of $30,000 per month (beginning on July 5, 2024) until the revenue participation interest is repurchased by the Company. The revenue participation interest is subject to a repurchase option by the Company. The repurchase price prior to May 31, 2024 is 140% or $420,000, the repurchase price after June 1, 2024 is 154% or $462,000, plus payments of $30,000 per month due on the fifth calendar day of each month until repurchased in its entirety. The repurchase price after June 1, 2024 is reduced by any amounts paid by the Company to the lender prior to that date. The Revenue Interest Purchase Agreement also requires the Company to make payments commencing after June 1, 2024 equal to 15.45% of the net proceeds received by the Company from the Regulation A Offering. In the event of default, the Company is obligated to pay an additional 25% of any and all amounts due, immediately.   462,000    - 
Working capital loan agreement structured as a Revenue Interest Purchase Agreement (“revenue participation interest”) with an individual domiciled in the state of California. The working capital loan provided for a purchase of an ownership interest in the revenues of our Champion subsidiary. The revenue participation interest requires payments of $50,000 per month (beginning on July 5, 2024) until the revenue participation interest is repurchased by the Company. The revenue participation interest is subject to a repurchase option by the Company. The repurchase price prior to May 31, 2024 is 140% or $700,000, the repurchase price after June 1, 2024 is 154% or $770,000, plus payments of $50,000 per month due on the fifth calendar day of each month until repurchased in its entirety. The repurchase price after June 1, 2024 is reduced by any amounts paid by the Company to the lender prior to that date. The Revenue Interest Purchase Agreement also requires the Company to make payments commencing after June 1, 2024 equal to 25.6% of the net proceeds received by the Company from the Regulation A Offering. In the event of default, the Company is obligated to pay an additional 25% of any and all amounts due, immediately.   770,000    - 
Working capital loan agreement with a limited liability company domiciled in the state of New York. The working capital loan is secured by all the assets of the Company that is not secured by the first priority interest of the major financial institution line of credit facility as well as a personal guaranty by our Chief Executive Officer, Mr. Charles A Ross. The working capital loan requires payments of $26,000 each for 64 weeks on the Friday following funding. The working capital loan is due and payable on June 20, 2025 with a final payment of $26,000. Interest rate approximates 40.95% per annum if the Company does not prepay the working capital loan prior to June 20, 2025.   1,088,440    - 
Working capital loan agreement with a limited liability company domiciled in the state of New York. The working capital loan is secured by all the assets of the Company that is not secured by the first priority interest of the major financial institution line of credit facility as well as a personal guaranty by our Chief Executive Officer, Mr. Charles A Ross. The working capital loan requires payments of $11,731 each for 62 weeks on the Friday following funding. The working capital loan was due and payable on December 27, 2024 with a final payment of $11,731.   -    500,000 
Working capital loan agreement with a limited liability company domiciled in the state of New York. The working capital loan is secured by all the assets of the Company that is not secured by the first priority interest of the major financial institution line of credit facility as well as a personal guaranty by our Chief Executive Officer, Mr. Charles A Ross (Secured Loan #1). The working capital loan requires payments of $20,000 each for 64 weeks on the Friday following funding. The working capital loan was due and payable on July 5, 2024 with a final payment of $20,000.   -    504,214 
           
Working capital loans  $3,731,790   $1,954,214 
           
Total recorded as a current liability  $3,731,790   $1,954,214 

 

16
 

 

At June 30, 2024, and December 31, 2023, the outstanding balance due on all of the working capital notes payable was $3,731,790 and $1,954,214, respectively.

 

NOTE 8 – GOODWILL AND ACQUISITION OF THE CHAMPION ENTITIES

 

Goodwill

 

Goodwill is initially recorded as of the acquisition date, and is measured as any excess of the purchase price over the estimated fair value of the identifiable net assets acquired. Goodwill is not amortized, but rather is subject to impairment testing annually (on the first day of the fourth quarter), or between annual tests whenever events or changes in circumstances indicate that the fair value of a reporting unit may be below its carrying amount. We first perform a qualitative assessment to evaluate goodwill for potential impairment. If based on that assessment it is more likely than not that the fair value of the reporting unit is below its carrying value, a quantitative impairment test is necessary. The quantitative impairment test requires determining the fair value of the reporting unit. We use the income approach, whereby we calculate the fair value based on the present value of estimated future cash flows using a discount rate that approximates our weighted average cost of capital. The process of evaluating the potential impairment of goodwill is subjective and requires significant estimates and assumptions about the future such as sales growth, gross margins, employment costs, capital expenditures, inflation and future economic and market conditions. Actual future results may differ from those estimates. If the carrying value of the reporting unit’s assets and liabilities, including goodwill, exceeds its fair value, impairment is recorded for the excess, not to exceed the total amount of goodwill allocated to the reporting unit.

 

As of June 30, 2024 and December 31, 2023, we had goodwill of $2,000,000 presented within other long-term assets in our consolidated balance sheets, directly related to our 2022 acquisition of the Champion Entities.

 

The Company will review its goodwill for impairment periodically (based on economic conditions) and determine whether impairment is to be recognized within its consolidated statement of operations. No impairment charges were recognized during the three months and six months ended June 30, 2024 and 2023.

 

NOTE 9 – INCOME TAXES

 

At June 30, 2024 and December 31, 2023, the Company had a net operating loss carry forward of $55,856,751 and $45,213,594, respectively, which begins to expire in 2034.

 

Components of net deferred tax asset, including a valuation allowance, are as follows:

 

   June 30, 2024   December 31, 2023 
   (unaudited)   (audited) 
Deferred tax asset:          
Net operating loss carryforward  $11,729,920   $9,494,850 
Total deferred tax asset   11,729,920    9,494,850 
Less: Valuation allowance   (11,729,920)   (9,494,850)
Net deferred tax asset  $-   $- 

 

Valuation allowance for deferred tax assets as of June 30, 2024, and December 31, 2023, was $11,729,920 and $9,494,850, respectively. In assessing the recovery of the deferred tax asset, management considers whether it is more likely than not that some portion or the entire deferred tax asset will not be realized. The ultimate realization of the deferred tax asset is dependent upon the generation of future taxable income in the periods in which those temporary differences become deductible. Management considers the scheduled reversals of future deferred tax assets, projected future taxable income, and tax planning strategies in making this assessment. As a result, management determined it was more likely than not deferred tax assets will not be realized as of June 30, 2024, and December 31, 2023, and recognized 100% valuation allowance for each period.

 

Reconciliation between the statutory rate and the effective tax rate for both periods and as of June 30, 2024 and December 31, 2023:

 

      
Federal statutory rate   (21.0)%
State taxes, net of federal benefit   (0.0)%
Change in valuation allowance   21.0%
Effective tax rate  0.0%

 

On August 16, 2022, the Inflation Reduction Act of 2022 (“the 2022 act”) was signed into law. The 2022 act contains numerous provisions, including a 15% corporate alternative minimum income tax on “adjusted financial statement income”, expanded tax credits for clean energy incentives and a 1% excise tax on corporate stock repurchases. The provisions of the 2022 act become effective for tax years beginning after December 31, 2023. On December 27, 2022, the IRS and Department of Treasury issued initial guidance for taxpayers subject to the corporate alternative minimum tax. The guidance addresses several, but not all, issues that needed clarification. The IRS and Department of Treasury intend to release additional guidance in the future. We will continue to evaluate the impact of the 2022 act as more guidance becomes available. We currently do not expect an impact on our consolidated financial statements.

 

17
 

 

NOTE 10 – SHARE CAPITAL

 

The Company is authorized to issue 600,000,000 shares of its $0.001 par value common stock and 10,000,000 shares of its $0.001 par value preferred stock. At June 30, 2024, the 10,000,000 shares of $0.001 par value preferred stock were comprised of 150,000 shares authorized and 125,000 shares issued and outstanding of its Series A convertible preferred stock, 350,000 shares authorized and 75,143 shares issued and outstanding of its Series B convertible preferred stock, 3,100,000 shares authorized and 0 shares issued and outstanding of its Series C convertible preferred stock, and 500,000 shares authorized and 133,334 shares issued and outstanding of its Series D convertible preferred stock.

 

On June 27, 2023, the Company effectuated a reverse split of its issued and outstanding shares of common stock at a ratio of 1-for-25. The share numbers and pricing information in this report are adjusted to reflect the reverse stock split for the 2023 comparative periods presented.

 

On April 23, 2024, the Company received notice from Nasdaq indicating that, while the Company has not regained compliance with the Bid Price Requirement, Nasdaq has determined that the Company is eligible for an additional 180-day period, or until October 21, 2024, to regain compliance. According to the notification from Nasdaq, the staff’s determination was based on (i) the Company meeting the continued listing requirement for market value of its publicly held shares and all other applicable Nasdaq initial listing standards, with the exception of the minimum bid price requirement, and (ii) the Company’s written notice to Nasdaq of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary. If at any time during this second 180-day compliance period, the closing bid price of the common stock is at least $1 per share for a minimum of 10 consecutive business days, Nasdaq will provide the Company with written confirmation of compliance. If compliance cannot be demonstrated by October 21, 2024, Nasdaq will provide written notification that the common stock will be delisted. At that time, the Company may appeal Nasdaq’s determination to a Hearings Panel.

 

On April 24, 2024, the Company received notice from Nasdaq indicating that Staff determined to grant the Company an extension until June 15, 2024 to regain compliance with the rule by holding an annual meeting of shareholders. At the annual meeting, shareholders must be afforded the opportunity to discuss company affairs with management and, if required by the company’s governing documents, to elect directors. The Company expects to hold an annual meeting within such timeframe. While the compliance plan is pending, the Company’s securities will continue to trade on NASDAQ.

 

On May 3, 2024, the Securities and Exchange Commission (the “Commission”) entered an order instituting settled administrative and cease-and-desist proceedings against BF Borgers CPA PC (“Borgers”) and its sole audit partner, Benjamin F. Borgers CPA, permanently barring Mr. Borgers and Borgers (collectively, “BF Borgers”) from appearing or practicing before the Commission as an accountant (the “Order”). As a result of the Order, BF Borgers may no longer serve as the Company’s independent registered public accounting firm, nor can BF Borgers issue any audit reports included in Commission filings or provide consents with respect to audit reports.

 

On May 3, 2024, the Company dismissed BF Borgers as its independent registered public accounting firm. The Company’s audit committee unanimously approved the decision to dismiss BF Borgers.

 

The Company is required to re-audit its financial statements for the years ending December 31, 2022 and 2023. The Company and its auditors are in process of completing these audits for the two years described above and if any changes to the financial statements are needed to be made the Company will issue a non-reliance notice to the public on Current Report on Form 8-K. No report is needed as of the date of this Report.

 

Common Stock and Preferred Stock

 

For the month of June 2023, the following transactions occurred: On June 27, 2023, we entered into a PIPE transaction with Armistice Capital for the purchase and sale of $2,993,850.63 of securities, consisting of (i) 71,499 shares of common stock at $4.37 per share, (ii) prefunded warrants (the “2023 Prefunded Warrants”) that are exercisable into 615,000 shares of common stock (the “ 2023 Prefunded Warrant Shares”) at $4.37 per Prefunded Warrant, and (iii) immediately exercisable warrants to purchase up to 686,499 shares of common stock at an initial exercise price of $4.24 per share and will expire five years from the date of issuance.

 

For the month of July 2023, the following transactions occurred: Approximately 1,493,272 shares of the Company’s common stock were issued pursuant to the 100-share lot roundup caused by the reverse stock split on June 27, 2023. The Depository Trust and Clearing Corporation (the “DTCC”) which handles the clearing and settlement of virtually all broker-to-broker equity, listed corporate and municipal bond and unit investment trust (UIT) transactions in the U.S. equities markets submitted numerous requests for share allocations. In connection with the Company’s June 27, 2023 1-for-25 reverse split DTCC made these requests. An additional 1.488 million shares of the Company’s common stock were newly issued and added to its post-reverse stock split numbers. As described in the Company’s Information Statement filed on Schedule 14C dated December 14, 2022, shareholders holding at least a “round lot” (100 shares or more) prior to the reverse stock split shall have no less than one round lot (100 shares) after the reverse stock split.

 

18
 

 

Pursuant to the PIPE transaction 71,499 shares of common stock were issued to Armistice Capital. The 2023 Prefunded Warrants held by Armistice Capital were not exercised for the month of July.

 

For the month of August 2023, the following transactions occurred: On August 21, 2023 245,000 of the 2023 Prefunded Warrants were exercised. Along with an exercise notice and payment totaling $2,450.00, 245,000 shares of common stock were issued.

 

For the month of September 2023, the following transactions occurred: On September 8, 2023, the Company, entered into an inducement offer letter agreement (the “Inducement Letter”) with Armistice Capital the holders of existing common stock purchase warrants to purchase shares of common stock of the Company. The existing common stock purchase warrants were issued on July 8, 2022 and June 28, 2023 and had an exercise price of $4.37 and $4.24, respectively per share.

 

Pursuant to the Inducement Letter, Armistice Capital agreed to exercise for cash their existing common stock purchase warrants to purchase an aggregate of 2,988,687 shares of the Company’s common stock at a reduced exercise price of $1.10 per share in consideration for the Company’s agreement to issue new common stock purchase warrants (the “New Warrants”), to purchase up to 5,977,374 shares of the Company’s common stock (the “New Warrant Shares”). The Company received aggregate gross proceeds of $3,287,555.70 from the exercise of the existing common stock purchase warrants by Armistice Capital. Armistice Capital received 2 New Warrant for each existing common stock purchase warrant that they exercised. No compensation or expense was recognized as the repricing of the existing common stock purchase warrants was in excess of the current market price of the Company’s common stock, and the New Warrants were not compensatory as well due to the market conditions. The Company issued 2,988,687 shares of the Company’s common stock, of which 2,242,000 shares of common stock are held in reserve by the Company’s transfer agent. Armistice Capital Fund Ltd. is limited to total ownership at one time to be no more than 9.99% of the Company’s issued and outstanding common stock. Armistice Capital took ownership and possession of 356,687 shares of common stock (September 21st) and 390,000 shares of common stock (September 12th), representing less than 9.99% ownership interest by Armistice Capital on such dates.

 

On September 8, 2023, 370,000 of the 2023 Prefunded Warrants were exercised. Along with an exercise notice and payment totaling $3,700.00, 370,000 shares of common stock were issued. On September 19, 2023, the Company issued 6,391 shares of common stock pursuant to the Company’s 2021 LTIP equity plan. The shares were valued at $4,984.98 with a per share value of $0.78 which was the Company’s common stock closing market price on the grant date and date of issuance. Under the 2021 LTIP equity plan 3,954 shares of common stock were issued to Mr. Ross our Chief Executive Officer and 2,237 shares of common stock were issued to Mr. Grau our President and Interim Principal Accounting Officer. Additionally, on September 19, 2023, 3,721 shares of common stock were granted and issued to a vendor associated with our current working capital loan. The shares were valued at $2,902.38 with a per share value of $0.78. On September 20, 2023, the Company issued 24,129 shares of common stock pursuant to the Company’s board compensation plan for its independent directors. The shares were valued at $18,096.75 with a per share value of $0.75 which was the Company’s common stock closing market price on the grant date as well as issuance date. The Company recognized approximately $228,000 in gain on settlement of debt through the issuance of 24,129 shares of common stock to its independent directors on this date.

 

Shares Reserved for Issuance Pursuant to Certain Executive Employment Agreements

 

The Company in connection with its employment agreement with Messrs. Ross, Grau and Lambrecht reserved for issuance 62,500,000 shares of its common stock that are convertible under the Series A preferred stock. Per Mr. Lambrecht’s employment agreement entered into on November 20, 2023, the share-award grant is to vest 1/4th upon the signing of Mr. Lambrecht’s employment, another 1/4th on January 1, 2024, another 1/4th on January 1, 2025 and the remaining 1/4th on January 1, 2026. Mr. Lambrecht’s employment agreement has a term running from November 20, 2023 through December 31, 2026, a term of 37 and ½ months. The Company values the shares granted and earned out, as well as the additional shares granted but not earned out in accordance with ASC 718 and employee share-awards. Market value for the Company’s publicly traded stock at the time of grant for Mr. Lambrecht’s shares was $0.369.

 

19
 

 

Per Mr. Ross’s amended employment agreement with an effective date of November 20, 2023, the already issued or existing share-award grant is to vest 1/5th on January 1, 2024, another 1/5th on January 1, 2025, 1/5th on January 1, 2026, 1/5th on January 1, 2027 and the remaining 1/5th on January 1, 2028. Mr. Ross’s amended employment agreement has an effective term running from November 20, 2023 through December 31, 2026, a term of 37 and ½ months. The Company values the shares granted and earned out, as well as the additional shares granted but not earned out in accordance with ASC 718 and employee share-awards. Market value for the Company’s publicly traded stock at the time of modification of the terms of the Series A preferred stock for Mr. Ross’s shares was $0.3501.

 

Per Mr. Grau’s amended employment agreement with an effective date of November 20, 2023, the already issued or existing share-award grant is to vest 1/5th on January 1, 2024, another 1/5th on January 1, 2025, 1/5th on January 1, 2026, 1/5th on January 1, 2027 and the remaining 1/5th on January 1, 2028. Mr. Grau’s amended employment agreement has an effective term running from November 20, 2023 through December 31, 2026, a term of 37 and ½ months. The Company values the shares granted and earned out, as well as the additional shares granted but not earned out in accordance with ASC 718 and employee share-awards. Market value for the Company’s publicly traded stock at the time of modification of the terms of the Series A preferred stock for Mr. Grau’s shares was $0.3501.

 

Shares Issued as Compensation

 

The Company in connection with various consulting and advisory agreements is required to issue shares of its common stock. The value of the shares issued is determined by the fair value of the Company’s common stock that trades on the Nasdaq Capital Market. This value on the date of grant is afforded to the Company for the recording of stock compensation to non-employees and the recognition of this expense over the period in which the services were incurred or performed. Most of the Company’s agreement for stock compensation provide for services to have been satisfied upon the initial grant, thereby incurring the cost immediately from the grant.

 

Stock-based compensation is presented in accordance with the guidance of ASC 718. Under the provisions of ASC 718, the Company is required to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our statements of operations. Where the stock-based compensation is not an award, option, warrant or other common stock equivalent, the Company values the shares based on fair value with respect to its grant date and the price that investors may have been paying for the Company’s common stock on that date in its various exempt private placement offerings.

 

Modified Terms of Series A Preferred Stock

 

On October 31, 2023, the Company board of directors approved amending and restating the certificate of designation of the Company’s Series A Convertible Preferred Stock to increase the number of shares from 100,000 to 150,000 and to allow for the conversion of the Series A Preferred Stock under certain circumstances and vesting requirements. On November 20, 2023 the Company issued 25,000 shares of its Series A Preferred Stock to Mr. Lambrecht, pursuant to his employment agreement as Chief Operating Officer. Mr. Lambrecht’s shares of Series A Preferred Stock will vest in the following manner, 25% upon signing of the employment agreement, 25% on the 1st of January 2024, and 25% for the following two anniversaries. Messrs. Ross and Grau who are holders of the Series A Preferred Stock will also enjoy the vesting of their shares of Series A Preferred Stock in the following manner; 20% on the 1st of January 2024 and 20% thereafter for the following 4 anniversaries. The Company has determined, and appropriately recorded in its statement of operations a compensation expense associated with the conversion or convertibility of the Series A Preferred Stock into common stock of the Company on a 500:1 basis. Based on the vesting schedule afforded to the holders of the Series A Preferred Stock, 3,125,000 shares of common stock could be issued upon the conversion of 6,250 shares of Series A Preferred Stock as of December 31, 2023, and immediately subsequent to December 31, 2023, another 13,125,000 shares of common stock could be issued upon the conversion of 26,250 shares of Series A Preferred Stock on January 1, 2024. The conversion of the Series A Preferred Stock is at the discretion of the holder unless there are special circumstances. The Company will recognize the stock compensation expense attributable to each awarded employee over the vesting term.

 

20
 

 

New Preferred Stock Series and Designations and Reg. A+ Offering

 

On November 3, 2023, the Company’s board of directors approved the designation of a new Series C Convertible Cumulative Preferred Stock (the “Series C Designation”).

 

The Company filed a registration statement on Form 1-A offering up to 2,666,666 shares of Series C Preferred Stock, at an offering price of $7.50 per share, for a maximum offering amount of $19,999,995. There is a minimum initial investment amount per investor of $300.00 for the Series C Preferred Stock and any additional purchases must be made in increments of at least $7.50. No Series C Preferred Stock was issued and outstanding at June 30, 2024 and December 31, 2023.

 

On May 10, 2024, the Company’s board of directors approved the designation of a new Series D Convertible Preferred Stock (the “Series D Designation”). The Series D Designation was filed by the Company with the Secretary of State of Nevada on May 10, 2024, and designated 2,500,000 shares of Series D Preferred Stock, $0.001 par value per share. The Series D Preferred Stock has the following rights:

 

Stated Value. Each share of Series D Preferred Stock has an initial stated value of $7.50, subject to appropriate adjustment in relation to certain events, such as recapitalizations, stock dividends, stock splits, stock combinations, reclassifications or similar events affecting the Series D Preferred Stock.

 

Conversion at Option of Holder. Each share of Series D Preferred Stock shall be convertible into shares of Common Stock at a fixed price per share of $1.50 (1 share of Series C Preferred Stock converts into 5 shares of Common Stock), at the option of the holder thereof, at any time following the issuance date of such share of Series D Preferred Stock at the Company’s office or any transfer agent for such stock. The conversion price ($1.50) shall not be adjusted for stock splits, stock dividends, recapitalizations or similar events.

 

Forced Conversion – If the closing price of the Company’s Common Stock during any ten consecutive trading day period has been at or above $2.25 per share (as adjusted for stock splits, stock dividends recapitalizations and similar events), then the Company shall have the right to require the holder of the Series D Preferred Stock to convert all, or any portion of, the shares of Series D Preferred Stock held by such holder for shares of Common Stock. If the Company elects to cause a forced conversion of the shares of Series D Preferred Stock, then it must simultaneously take the same action with respect to all of the other shares of Series D Preferred Stock then outstanding on a pro rata basis.

 

Voting Rights. The Series D Preferred Stock has no voting rights relative to matters submitted to a vote of the Company’s stockholders (other than as required by law). The Company may not amend its articles of incorporation or the Series D Designation (whether by merger, consolidation, or otherwise) to materially and adversely change the rights, preferences or voting power of the Series D Preferred Stock without the affirmative vote of at least two-thirds of the votes entitled to be cast on such matter by holders of the Company’s outstanding shares of Series D Preferred Stock, voting together as a class.

 

Conversion of Revenue Interest Loan for Preferred Stock Series D and Potential Issuance of Common Stock Equivalents from the Conversion of Series D

 

On May 13, 2024 the Company and the holder of the Revenue Interest Loan #1 entered into a settlement and conversion agreement (“Securities Exchange Agreement”) whereby the Company is to issue a certain number of shares of Series D convertible preferred stock as full satisfaction for the revenue participation interest agreement or loan. The Series D convertible preferred stock was purchased at $7.50 per share. Total loan balance and premium payment for inducement for Revenue Interest Loan #1 on the date of settlement and conversion was $1,000,005. The Series D convertible preferred stock is convertible at the option of the holder into common stock of the Company at a fixed price per share of $1.50 per share.

 

21
 

 

The Company issued one hundred thirty-three thousand three hundred thirty-four (133,334) shares of the Series D Preferred Stock. The Securities Exchange Agreement is intended to be effected as an exchange of securities issued by the Company pursuant to Section 3(a)(9) of the Securities Act. For the purposes of Rule 144, the Company acknowledges that the holding period of the Securities Exchange Agreement (and upon conversion thereof, if any, into shares of the Company’s common stock) may be tacked onto the holding period of the Series D Preferred Stock received by the holder. The Company agrees not to take a position contrary to this unless required by regulatory authorities and their determination to the contrary.

 

At June 30, 2024 and December 31, 2023, there were 22,129,920 and 9,004,920 shares of common stock issued (which includes reserved for) and outstanding, respectively; and 75,143 and 75,143 shares of Series B preferred stock issued and outstanding, respectively, and 125,000 and 125,000 shares of its Series A preferred stock issued and outstanding, respectively; and 133,334 and 0 shares of its Series D preferred stock issued and outstanding, respectively. No Series C preferred stock was issued or outstanding at June 30, 2024 or December 31, 2023.

 

NOTE 11 – WARRANTS AND OPTIONS

 

As of June 30, 2024, no Prefunded Warrants remained issued and outstanding with respect to the July PIPE transaction. The Prefunded Warrants were purchased in their entirety by the holders of the warrants for $27.50 per warrant. The Prefunded Warrants required the payment of an additional $0.25 per warrant and the written notice of exercise to the Company to convert the Prefunded Warrant into one share of common stock of the Company. During the period from July 12, 2022 through December 31, 2023, the Company received notice on 448,096 Prefunded Warrants converting into 448,096 shares of common stock.

 

Calvary Fund exercised all of its Calvary Warrants by November 30, 2022 requiring the payment of an additional $0.25 per warrant and the written notice of exercise to the Company to convert the Calvary Warrant into one share of common stock of the Company. Calvary Fund continues to hold the 15,099 warrants exercisable at a price of $129.6875 per warrant.

 

Along with the Prefunded Warrants the PIPE investors were issued immediately exercisable warrants to purchase up to 936,937 shares of the Company’s common stock with an exercise price of $21.50 per share expiring five years from the date of issuance, or July 11, 2027. Each Prefunded Warrant and share of common stock issued in the PIPE transaction received two warrants that were exercisable at $21.50 per share with a five-year expiry. None of these warrants have been exercised by the holders.

 

22
 

 

On June 27, 2023, we entered into a PIPE transaction with Armistice Capital for the purchase and sale of $2,993,850.63 of securities, consisting of (i) 71,499 shares of common stock at $4.37 per share, (ii) prefunded warrants (the “2023 Prefunded Warrants”) that are exercisable into 615,000 shares of common stock (the “2023 Prefunded Warrant Shares”) at $4.37 per Prefunded Warrant, and (iii) immediately exercisable warrants to purchase up to 686,499 shares of common stock at an initial exercise price of $4.24 per share and will expire five years from the date of issuance. The 686,499 warrants were repriced to $1.10 per share as part of the Inducement Letter and exercise terms with Armistice Capital.

 

On September 8, 2023, the Company, entered into an inducement offer letter agreement with Armistice Capital the holders of existing common stock purchase warrants to purchase shares of common stock of the Company. The existing common stock purchase warrants were issued on July 8, 2022 and June 28, 2023 and had an exercise price of $4.37 and $4.24, respectively per share.

 

Pursuant to the Inducement Letter, Armistice Capital agreed to exercise for cash their existing common stock purchase warrants to purchase an aggregate of 2,988,687 shares of the Company’s common stock at a reduced exercise price of $1.10 per share in consideration for the Company’s agreement to issue new common stock purchase warrants (the “New Warrants”), to purchase up to 5,977,374 shares of the Company’s common stock (the “New Warrant Shares”). The Company received aggregate gross proceeds of approximately $3,287,555.70 from the exercise of the existing common stock purchase warrants by Armistice Capital. Armistice Capital received 2 New Warrant for each existing common stock purchase warrant that they exercised. No compensation or expense was recognized as the repricing of the existing common stock purchase warrants was in excess of the current market price of the Company’s common stock, and the New Warrants were not compensatory as well due to the market conditions. The Company issued 2,988,687 shares of the Company’s common stock, of which 2,242,000 shares of common stock are held in reserve by the Company’s transfer agent. Armistice Capital Fund Ltd. is limited to total ownership at one time to be no more than 9.99% of the Company’s issued and outstanding common stock. Armistice Capital took ownership and possession of 356,687 shares of common stock (September 21st) and 390,000 shares of common stock (September 12th), representing less than 9.99% ownership interest by Armistice Capital on such dates. The common stock purchase warrants that were induced into being exercised were all held by Armistice Capital and consisted of the July 12, 2022 immediately exercisable warrants with an exercise price of $21.50, the additional issuance of warrants to Armistice Capital that contractually were part of the July 12, 2022 issuance but were triggered by the June 27, 2023 offering that occurred with Armistice Capital and resulting in an additional 1,365,251 immediately exercisable warrants with an exercise price of $21.50, along with 686,499 immediately exercisable warrants with an exercise price of $4.24 that were issued on June 27, 2023.

 

On August 21, 2023, 245,000 of the 2023 Prefunded Warrants were exercised. Along with an exercise notice and payment totaling $2,450.00, 245,000 shares of common stock were issued. On September 8, 2023 370,000 of the 2023 Prefunded Warrants were exercised. Along with an exercise notice and payment totaling $3,700.00, 370,000 shares of common stock were issued. A total of 615,000 2023 Prefunded Warrants were exercised along with 746,687 warrants per the Inducement Letter.

 

Along with the Prefunded Warrants the previous year’s PIPE investors were issued immediately exercisable warrants to purchase up to 936,937 shares of the Company’s common stock with an exercise price of $21.50 per share expiring five years from the date of issuance, or July 11, 2027. Each Prefunded Warrant and share of common stock issued in the PIPE transaction received two warrants that were exercisable at $21.50 per share with a five-year expiry. None of these warrants have been exercised by the holders. These warrants were repriced to $1.10 per share as part of the Inducement Letter and exercise agreement by and between Armistice Capital and the Company.

 

As of June 30, 2024 and December 31, 2023, there were 6,136,892 warrants issued and outstanding to acquire additional shares of common stock.

 

The Company evaluates outstanding warrants as derivative liabilities and will recognize any changes in the fair value through earnings. The Company determined that the warrants have an immaterial fair value at December 31, 2023 and June 30, 2024. The warrants do not trade in a highly active securities market, and as such, the Company estimated the fair value of these common stock equivalents using Black-Scholes and the following assumptions:

 

23
 

 

Expected volatility was based primarily on historical volatility. Historical volatility was computed using daily pricing observations for recent periods. The Company believes this method produced an estimate that was representative of the Company’s expectations of future volatility over the expected term which due to their maturity period as expiry, it was three years. The Company had no reason to believe future volatility over the expected remaining life of these common stock equivalents was likely to differ materially from historical volatility. Expected life was based on three years due to the expiry of maturity. The risk-free rate was based on the U.S. Treasury rate that corresponded to the expected term of the common stock equivalents.

 

   June 30, 2024   December 31, 2023 
   (unaudited)   (audited) 
         
Stock Price  $0.47   $0.31 
Exercise Price  $1.10   $1.10 
Term (expected in years)   4.1    4.7 
Volatility   54.84%   17.18%
Annual Rate of Dividends   0.0%   0.0%
Risk Free Rate   5.09%   4.79%
Measurement input          

 

Stock Purchase Warrants

 

The following table summarizes all warrant activity for the year ended December 31, 2023, and for the six months ended June 30, 2024.

 

   Shares   Weighted- Average Exercise Price Per Share   Remaining term   Intrinsic value 
                 
Outstanding and Exercisable at December 31, 2022 (audited)   1,096,455   $30.50    4.50 years    - 
Granted   615,000   $4.37    5.00 years    - 
Granted in Debt Conversion   686,499   $4.24    5.00 years    - 
Granted Prefunded Warrants   1,365,251   $1.10    4.00 years    - 
Granted in PIPE transaction   5,977,374   $1.10*   5.00 years    - 
Exercised   (3,603,687)  $0.88    5.00 years    - 
Expired   -    -    -    - 
Outstanding and Exercisable at December 31, 2023 (audited)   6,136,892   $3.15    4.70 years    - 
Granted   -   $-    -    - 
Exercised   -   $-    -    - 
Expired   -   $-    -    - 
Outstanding and Exercisable at June 30, 2024 (unaudited)   6,136,892   $3.15    4.10 years    - 

 

  - *Pursuant to the Inducement Agreement the following warrants were repriced with an exercise price of $1.10 per warrant.

 

24
 

 

NOTE 12 – LEASES AND LEASED PREMISES

 

Rental Payments under Non-cancellable Operating Leases and Equipment Leases

 

The Company through its purchase of Champion acquired several long-term (more than month-to-month) leases for two manufacturing facilities, three office spaces, five distribution centers and five retail spaces. Four of its distribution centers also have retail operations for which it leases its facilities. Lease terms on the various spaces’ expiry from a month-to-month lease (30 days) to a long-term lease expiring in September of 2028.

 

Rent expense for operating leases totaled approximately $185,000 and $225,000 and $370,000 and $450,000 for the three and six-months ended June 30, 2024, and 2023, respectively. These amounts are included in our condensed consolidated statement of operations in Rental expense, warehousing, outlet expense and Administrative and other. Rental expense, warehousing, outlet expense is specific to warehousing and final manufacturing of our products.

 

The Company does not have any equipment leases whereby we finance this equipment needed for operations at competitive finance rates. New equipment to be financed in the near term, if necessary, may not be obtainable at competitive pricing with increasing interest rates.

 

Right of Use Assets and Lease Liabilities

 

Lease expense for operating leases consists of the lease payments plus any initial direct costs, net of lease incentives, and is recognized on a straight-line basis over the lease term.

 

The Company’s operating leases are comprised primarily of facility leases and as such we have no finance leases for our vehicles or equipment currently at this time. The Company added approximately $1,000,000 in right-of-use lease assets offset by right-of-use lease liabilities during the 4th quarter for the year ended December 31, 2023, this included multiple leases that were increased in size and as well as several leases that were extended or options to extend were added in the lease terms.

 

Balance sheet information related to our leases is presented below:

 

   Balance Sheet location  June 30, 2024   December 31, 2023 
      (unaudited)   (unaudited) 
Operating leases:             
Right-of-use lease assets  Right-of-use operating lease assets  $1,312,831   $1,946,567 
Right-of-use lease liability, current  Other current liabilities   791,222    1,039,081 
Right-of-use lease liability, long-term  Right-of-use operating lease liability   521,609    907,486 

 

25
 

 

Other information related to leases is presented below:

 

   2024   2023 
   Six Months Ended June 30, 
   2024   2023 
   (unaudited)   (unaudited) 
Cash Paid for Amounts Included in Measurement of Liabilities:          
Operating cash flows from operating leases  $328,118   $243,501 
Weighted Average Remaining Lease Term:          
Operating leases   2.8 years    3.0 years 
Weighted Average Discount Rate:          
Operating leases   10.00%   5.00%

 

The minimum future annual payments under non-cancellable leases during the next five years and thereafter, at rates now in force, are as follows:

 

   Operating leases 
July 1, 2024 – June 30, 2025  $638,836 
July 1, 2025 – June 30, 2026   312,295 
July 1, 2026 – June 30, 2027   267,302 
July 1, 2027 – June 30, 2028   256,782 
July 1, 2028 – June 20, 2029   64,754 
Thereafter   - 
Total future minimum lease payments, undiscounted   1,539,969 
Less: Imputed interest   (227,138)
Present value of future minimum lease payments  $1,312,831 

 

NOTE 13 – COMMITMENTS AND CONTINGENCIES

 

Legal Proceedings

 

Various claims and lawsuits, incidental to the ordinary course of our business, may be brought against the Company from time-to-time. In the opinion of management, and after consultation with legal counsel, resolution of any of these matters (of which there are none) is not expected to have a material effect on the condensed consolidated financial statements.

 

Contractual Obligations

 

The Company does not believe there are any off-balance sheet arrangements that have, or are reasonably likely to have, a material effect on the condensed consolidated financial statements. As of June 30, 2024 and December 31, 2023 there were no outstanding letters of credit issued during the normal course of business. These letters of credit could reduce our available borrowings. During the six months ended June 30, 2024 the Company continues to hold a line of credit with a major financial institution. The amount due on the line of credit as of June 30, 2024 was $1,992,129. The Company is currently not in compliance with its terms and covenants; however, it intends on renegotiating the terms and covenants of the line of credit.

 

Executive Employment Agreements and Independent Contractor Agreements

 

The Company has written employment agreements with various other executive officers. All payments made to its executive officers and significant outside service providers are analyzed and determined by the board of directors’ compensation committee; some payments made to independent contractors (or officer payments characterized as non-employee compensation) may be subject to backup withholding or general withholding of payroll taxes, may make the Company responsible for the withholding and remittance of those taxes. Generally outside service providers are responsible for their own withholding and payment of taxes. Certain state taxing authorities may otherwise disagree with that analysis and Company policy.

 

26
 

 

NOTE 14 – OTHER INCOME – EMPLOYEE RETENTION CREDIT

 

The Company retained the services of a tax service professional to provide the Company with the specialized tax services. The services included identifying various tax initiatives as well as specifically tasking the tax service professional in applying for and the preparation of tax filings for (tax) credits available under the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”). During the year ended December 31, 2023, the Company received approximately $1,291,000 in tax credits under the CARES Act from the US Department of Treasury and paid approximately $178,000 to the service provider, netting the Company approximately $1,113,000 in credits for the retaining of its employees during COVID.

 

NOTE 15 – SUBSEQUENT EVENTS

 

The Company evaluated all events that occurred after the balance sheet date of June 30, 2024, through the date the financial statements were issued and determined that there were the following subsequent events:

 

The maturity date on the Champion line of credit was initially extended by Bank of America to April 30, 2024. The balance at the maturity date was approximately $1.9 million and access to the line of credit with Bank of America was terminated. Champion and Bank of America have continued dialogue and the Company is working with Bank of America regarding term loan repayment options.

 

On July 2, 2024, American Rebel, Inc., a wholly-owned subsidiary of the Company, entered into a Standard Merchant Cash Advance Agreement (the “Factoring Agreement”), with an accredited investor lending source (“Financier”). Under the Factoring Agreement, our wholly-owned subsidiary sold to Financier a specified percentage of its future receipts (as defined by the Factoring Agreement, which include any and future revenues of Champion Safe Company, Inc. (“Champion”), another wholly-owned subsidiary of the Company, and the Company) equal to $357,500 for $250,000, less origination and other fees of $12,500. Our wholly-owned subsidiary agrees to repay this purchased receivable amount in equal weekly installments of $17,875. Financier has specified customary collection procedures for the collection and remittance of the weekly payable amount including direct payments from specified authorized bank accounts. The Factoring Agreement expressly provides that the sale of the future receipts shall be construed and treated for all purposes as a true and complete sale and includes customary provisions granting a security interest under the Uniform Commercial Code in accounts and the proceeds, subject to existing liens. The Factoring Agreement also provides customary provisions including representations, warranties and covenants, indemnification, arbitration and the exercise of remedies upon a breach or default. The obligations of our wholly-owned subsidiary, Champion and the Company under the Factoring Agreement are irrevocably, absolutely, and unconditionally guaranteed by Charles A. Ross, Jr., the Company’s Chairman and Chief Executive Officer. The Personal Guaranty of Performance by Mr. Ross to Financier provides customary provisions, including representations, warranties and covenants.

 

On July 8, 2024, the Company, and two of its subsidiaries (American Rebel, Inc. and Champion Safe Company, Inc.) entered into a subordinated business loan and security agreement (“Loan”) with an accredited investor lending source and a subsidiary to that accredited investor lending source as collateral agent, which provides for a term loan in the amount of $1,312,500 which principal and interest (of $577,500) is due on January 20, 2025. Commencing July 15, 2024, the Company is required to make weekly payments of $67,500 until the due date. The loan may be prepaid subject to a prepayment fee. An administrative agent fee of $62,500 was initially paid on the loan. A default interest rate of 5% becomes effective upon the occurrence of an event of default. In connection with the loan, the holder was issued a subordinated secured promissory note, dated July 8, 2024, in the principal amount of $1,312,500 which note is secured by all of the borrower’s assets, including receivables, subject to certain outstanding liens and agreements.

 

On July 10, 2024, the Company entered into a Conversion Agreement (the “Conversion Agreement”) with Series D convertible preferred stock holder, pursuant to which the holder agreed to convert the 133,334 shares of Series D convertible preferred stock it held into 2,232,143 shares of common stock, par value $0.001 per share, of the Company. The shares of common stock underlying the Series D convertible preferred stock was reduced and repriced from $1.50 per share to $0.448 per share (which this price represents the closing price for the Company’s common stock on NASDAQ for the day immediately preceding the date of the Conversion Agreement).

 

As a result of the July 10, 2024 conversion of Series D convertible preferred stock, the exercise price of 2,988,687 current warrants was reduced from $1.10 per share to $0.448 per share.

 

On July 22, 2024, the Company and an accredited investor lending source entered into an agreement whereby $300,000 of the Assumption Loan was acquired by the accredited investor lending source from the original holder. The agreement entered into was structured as an installment purchase between the two accredited investor lending sources. The Company entered into an amended note payable, which by its terms became a $